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Abstract (max. 2000 char.): 
New treatment and clinical imaging techniques have created a need 
for accurate and practical in vivo dosimeters in radiation medicine. 
This work describes the development of a new optical-fiber 
radiation dosimeter system, based on radioluminescence (RL) and 
optically stimulated luminescence (OSL) from carbon-doped 
aluminium oxide (Al2O3:C), for applications in radiotherapy and 
mammography. This system offers several features, such as a small 
detector, high sensitivity, real-time read-out, and the ability to 
measure both dose rate and absorbed dose. Measurement protocols 
and algorithms for the correction of responses were developed to 
enable a reliable absorbed dose assessment from the RL and OSL 
signals. 
At radiotherapy energies, the variation of the signal with beam 
parameters was smaller than 1% (1 SD). Treatment-like 
experiments in phantoms, and in vivo measurements during 
complex patient treatments (such as intensity-modulated radiation 
therapy) indicate that the RL/OSL dosimetry system can reliably 
measure the absorbed dose within 2%. The real-time RL signal also 
enables an individual dose assessment from each field. 
The RL/OSL dosimetry system was also used during 
mammography examinations. In such conditions, the 
reproducibility of the measurements showed to be around 3%. In 
vivo measurements on three patients showed that the presence of the 
RL/OSL probes did not degrade the diagnostic quality of the 
radiograph and that the system could be used to measure exit doses 
(i.e., absorbed doses on the inferior surface of the breast). A Monte 
carlo study proved that the energy dependence of the RL/OSL 
system at these low energies could be reduced by optimizing the 
design of the probes. 
It is concluded that the new RL/OSL dosimetry system shows 
considerable potential for applications in both radiotherapy and 
mammography. 
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1 In vivo dosimetry in
radiation medicine
In vivo dosimetry is the final stage in a long series of quality assurance (QA)
procedures in radiation medicine. As the term in vivo indicates, these mea-
surements are generally performed during patient treatment or diagnostic
examination, and the measuring instrument is either positioned inside the
patient, on the patient’s skin or as close as possible. The other quality as-
surance procedures are performed in phantoms (i.e., in the absence of the
patient) in order to check the behavior of the medical apparatus (linear ac-
celerator, or diagnostic imaging unit) or the validity of a computer-designed
treatment plan. Today, the use of in vivo dosimetry is increasing follow-
ing recommendation by many national and international organizations. New
diagnostic and treatment techniques like intensity modulated radiation ther-
apy (IMRT) introduce new challenges and requirements, such as the need to
provide real-time dosimetry devices with high spatial resolution, sensitivity
and accuracy. Such in vivo dosimeters can identify deviations in the deliv-
ery of standard or complex treatments, evaluate the dose to radio-sensitive
organs or estimate the absorbed dose delivered in situations where computer
calculations are not reliable (for example at interfaces between tissue and
air (lungs, skin), tissue and bone, etc). Several in vivo dosimetry systems
are available, but have pitfalls in terms of accuracy or require considerable
investments in time and money. These factors have so far greatly limited the
widespread application of in vivo dosimetry. In order to fully understand the
role and implications of in vivo dosimetry, it is necessary to know the goals
of the medical procedures involving radiation, as well as the risk associated
with them. In this chapter, the philosophy of radiotherapy and imaging is
briefly outlined, and some of the most popular in vivo dosimetry devices are
reviewed. In view of the topic of this thesis work, the discussion will be lim-
ited to two subfields: external radiation therapy and mammography. These
two disciplines differ in terms of medical intent and the magnitude of the ra-
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diation doses involved. Both situations are however carefully regulated and
monitored. Whenever necessary, the relevant physical concepts are described
but a full description of the science of dosimetry is beyond the scope of this
work.
1.1 Radiotherapy
Radiotherapy (or “radiation therapy”) describes the use of ionizing radiation
such as photons and electrons, and to a lesser extent, protons and neutrons
to treat a critical condition such as a cancerous tumor. The term “external
radiation therapy” is also used to differentiate treatments delivered by linear
accelerators or “linacs” from brachytherapy treatments (where the radioac-
tive source is positioned near the tumor, often inside the patient’s body).
Most radiotherapy treatments involve high-energy x-rays (4 to 25 MV), but
high energy electron beams (6-22 MeV) are also used, either alone or in
conjunction with photon beams. The patient is generally affected by a life-
threatening disease, and will be requiring a long (5-7 weeks) and difficult
(side-effects) treatment procedure. Conventional external therapy and in-
tensity modulated radiation therapy (IMRT) are two kinds of treatments
differing in their technological complexity. They are illustrated in figure 1.1
and are detailed below.
1.1.1 Conventional external therapy
For a patient treated with external radiation therapy, the process is the fol-
lowing: the extent of the volume to be treated (usually referred to as “target
volume”) is delineated on computerized tomography (CT) images of the pa-
tient before the beginning of the treatment. These CT data (containing the
patient specific 3D anatomy information) are then transferred to a comput-
erized treatment planning system (TPS), where the physical details of the
radiation beams are going to be defined (such as the angles and the en-
ergy). The TPS will then calculate a 3D dose distribution, according to an
algorithmic modeling of radiation interactions with matter. Several beam
combinations can be achieved by trial and error before the optimal dose
distribution is achieved. In most conventional therapy cases, no additional
quality assurance (QA) check is performed. The treatment itself is typically
divided into 25 fractions of 2 Gy, in order to deliver a total absorbed dose of
50 Gy to the target volume. In vivo dosimetry may or may not be performed
in conventional treatments, depending on the institution’s practices.
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(b)
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Linac
- patient with fatal condition
- high energy: 6-20 MeV
- x-rays, electrons
- doses measured: 1-2 Gy
(a) entrance point
(b) exit point
(c) intracavitary point
(d) 2D measurement
conventional 
therapy IMRT
Figure 1.1: Characteristics of external radiation therapy and differences between conven-
tional treatments and IMRT. In conventional treatments, few beams are used and a high
dose is delivered to the tumor and to some healthy tissue. In IMRT, many small mod-
ulated beams are used, resulting in “tailored” dose delivery to the target volume. As a
result, healthy tissue is spared.
1.1.2 IMRT
Intensity Modulated Radiation Therapy (IMRT) is arguably one of the most
sophisticated forms of radiation treatments available today. As opposed to
conventional radiation therapy, many fields and beam angles are used, and the
dose delivery is modulated by a multi-leaf collimator (MLC) within each field.
Figure 1.1 illustrates these differences: the dose distribution is conforming
closely to the tumor. As a result, high dose gradients are observed outside
the target volume (because of the sharp dose fall-off) and some healthy tissue
is spared. The treatment planning softwares used in IMRT are based on a
method called “inverse planning”: the target volume, the critical organs, as
well as some dose constraints are entered in the TPS, and the algorithm
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itself calculates the optimal beam parameters, instead of the “trial and error”
approach used in conventional TPS. Because of this, IMRT is significantly
more “computer-dependent” than conventional treatments: the treatment
parameters are almost entirely chosen by the planning software. Hence, a
dosimetry check of the dose calculation in a solid water phantom is usually
performed before the treatment. Additionally, in vivo dosimetry is strongly
recommended.
The role of in vivo dosimetry in radiation therapy is two-fold:
1. to verify the calculations of the TPS at interfaces, i.e. close to the skin.
2. to evaluate the target dose in order to verify the treatment delivery
process.
The former goal can be reached by using “entrance” and “exit” detectors,
positioned on the patient’s skin during treatment (see positions (a) and (b)
in figure 1.1). According to the European Society for Therapeutic Radiation
Therapy (ESTRO), the latter condition can only be fulfilled when detec-
tors are inserted in natural body cavities (position (c) in figure 1.1), because
of all the potential errors associated with entrance and exit measurements
(Van Dam and Marinello, 1994). There is no universal agreement on the
benefits of in vivo dosimetry (Feldman et al., 2001), but several large scale
studies (Noel et al., 1995; Fiorino et al., 2000) confirmed that in vivo checks
can detect systematic errors as well as estimate the accuracy of the treatment
delivery. It is also recognized that major errors, such as the over-exposure
of 28 patients in Panama (IAEA, 2001) in 1991, would have been avoided if
an in vivo dosimetry program had been in place. For this reason, the use of
in vivo dosimetry is recommended by international agencies (AAPM (TG40,
1994), ICRU (ICRU, 1976), NACP (NACP, 1980), ICRP (ICRP, 2000)).
The frequency of in vivo measurements varies greatly among institutions.
In Sweden, for example, it is common practice to perform in vivo entrance
measurements for each patient and each treatment fraction. Other institu-
tions choose to do in vivo checks once for each patient, or only for specific
groups of patients (such as those treated with IMRT or other high-precision
techniques). Nonetheless, in vivo dosimetry is performed in relatively few
institutions because of time or financial constraints and its widespread use
depends on the availability of user-friendly, affordable dosimeters.
1.1.3 Required accuracy
The aim of a radiation therapy treatment can be crudely summarized as:
“give a sufficient dose to the tumor to guarantee tumor control as long as
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the probability of serious side effects remains sufficiently low”. As a result,
the tumor control probability (TCP) has to be balanced against the normal
tissue complication probability (NTCP). For some types of cancer, those
probability curves are well defined and helped establish that the outcome of
a radiotherapy treatment depends on doses that do not vary by more than
± 5 % about the optimum. This accuracy requirement is generally extended
to all treatments, though some studies highlight the need of higher accuracy
in some situations (Mijnheer et al., 1987; Dutreix, 1984).
1.2 Diagnostic radiology and mammography
Diagnostic radiology uses x-rays to help diagnose disease and injury. This
discipline includes among others traditional x-ray imaging, CT imaging and
mammography. In this work, the discussion will focus on mammography.
Mammography refers to the imaging of the human breast and is mostly used
as a screening tool to detect early breast cancer. Breast cancer is the most
frequent cancer among women, and its incidence is generally increasing all
over the world. The purpose of screening mammography is to obtain an image
of the breast where potential malignancies can be identified and, ideally,
not be confused with benign growth in the glandular breast tissue. The
main characteristics and goals of mammography are summarized in figure
1.2. The x-ray energies encountered in mammography are low (23-35 kV),
and the absorbed doses measured are of the order of 1 mGy. A higher dose
will usually lead to a better contrast in the diagnostic image. However, as
with any exposure to radiation, there is a small but significant risk that
the x-ray exposure will induce a cancer in the radiosensitive breast tissue
(BEIR, 1991). Since screening mammography involves potentially healthy
subjects, as opposed to radiotherapy where the clinical intent is to cure an
often deadly disease, the risk of the procedure has to be carefully balanced
against the benefits.
1.2.1 International recommendations and regulations
In mammography, doses are small and do not approach the threshold for
deterministic1 effects. However, radiation-induced stochastic events are of
concern. As a result, it is crucial to optimize both the equipment and the
1The probability of occurrence of stochastic effects increases with increasing dose, but
their severity does not. Deterministic effects, on the other hand, increase in severity with
increasing absorbed dose (examples include cataract, reddening of the skin, etc.)
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x-ray tube
(a)
(b)
film cassette tray
- healthy person coming for 
screening
-low energy x-rays (20-35 kV)
- absorbed doses: 1-2 mGy
(a) : entrance dose point
(b) : exit dose point
Goal:
- High contrast vs. 
dose to patient
- identify potential 
malignancies
Figure 1.2: Main characteristics of a mammography screening. The goal is to obtain a
high quality (high contrast) image at an acceptable dose.
imaging technique in order to produce the best diagnostic image at the low-
est possible dose (following the “as low as reasonably achievable” (ALARA)
recommendations for radiation protection). With modern equipment and
techniques, the absorbed dose delivered to the breast per image is about 1-2
mGy but this number can vary considerably depending on the choice of tech-
nique (target/filtration combination) and the characteristics of the breast
imaged (density, thickness, etc.). Some new imaging techniques (such as dig-
ital mammography) are also emerging and may result in a higher exposure in
order to obtain a superior diagnostic image. Accordingly, there are interna-
tional demands on quality control in mammography (Zoetelief et al., 1996).
In Sweden, there is an additional requirement to make direct patient mea-
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surements in mammography screening for at least 20 patients each year (SSI,
2002) using the European protocol on dosimetry in mammography (Zoetelief
et al., 1996).
1.2.2 Dosimetry in mammography
The radiation risk is best characterized by the average dose to the glandular
tissue of the breast (Zoetelief et al., 1996). The average glandular dose (or
“mean glandular dose”) can not be measured directly, but can be derived
from the entrance surface dose (i.e., the absorbed dose at the top of the
breast). Air is used as the reference medium (as opposed to radiation ther-
apy dosimetry, where water is now the medium of reference) and all quality
assurance dosimetry is performed using ionization chambers, in the absence
of patients. If in vivo measurements are performed, thermoluminescence
dosimeters (TLDs) on the breast can be used as a simple method of deter-
mining the dose received by the patient. However, TLDs have only a limited
accuracy in these conditions and an uncertainty of the order of 30% can be
expected on the measurements (Zoetelief et al., 1996). Hence, an in vivo
dosimetry system with an increased sensitivity and precision is desirable.
1.3 Current in vivo dosimetry techniques
Thermoluminescence dosimeters, semiconductor diodes and films are the
tools most commonly used in in vivo dosimetry to date. The purpose of
this section is to offer a brief overview of their characteristics, and highlight
potential pitfalls.
1.3.1 The standard: ionization chambers
The “state of the art” of radiation dosimeters is without doubt the ionization
chamber (or ion chamber).Different types of ionization chambers are avail-
able, from “free-air” (used only in standards labs) to cylindrical chambers
(most commonly used in radiation therapy) or parallel plate chambers (used
for electron dosimetry or in diagnostic radiology). When the chamber (con-
nected to an electrometer) is exposed to radiation, ion pairs are created in
the sensitive air volume. A high voltage applied across the chambers enables
these ion pairs to be collected, and the resulting current can be converted to
absorbed dose after the application of several correction factors. Those cor-
rection factors include: correction for atmospheric conditions (temperature
and pressure), for recombination of the ion pairs within the air volume, etc.
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In standard conditions with well-defined correction factors, ionization cham-
bers are extremely precise and accurate, making them an invaluable tool for
QA measurements. Though some sealed ionization chambers can be used
for in vivo measurements, their current use is mostly limited to phantom
measurements.
1.3.2 Thermoluminescence dosimeters
When certain crystalline materials are heated following irradiation, they emit
light proportionally to the amount of radiation dose absorbed. This principle,
known as thermoluminescence, has been recognized for several decades for its
potential in dosimetry (see chapter 2). Today, thermoluminescence dosime-
ters (TLDs) are used both in radiation therapy and in diagnostic radiology
(Berni et al., 2002). TLDs offer the best option for in vivo measurements in
mammography because of their high sensitivity and small size: they can be
placed anywhere on the skin or inside the body without the inconvenience of
cables. In regions of high dose gradients, several TLDs can be used to ob-
tain many dose points over an area of interest. Lithium fluoride is the most
popular TLD material because of its tissue equivalence (Zeff '8, compared
to about 7 for tissue2) and high sensitivity: it can be used to measure dose
ranging from 10 µGy to 103 Gy (Johns and Cunningham, 1983). However,
TLDs suffer from sensitivity variations between readings. As a result, they
have to be calibrated before every use. Annealing (i.e., resetting the TLDs by
heating them) needs to be performed after each measurement. With great
care in manipulation from an experienced technician, a reproducibility of
about 2% can be reached (Johns and Cunningham, 1983). The overall TLD
handling process is a time consuming procedure, which can take up to several
hours. Another major pitfall of TLDs is their relatively low precision in daily
clinical uses. As a result, the total uncertainty on dose determination can
be high: one study reported deviations up to 7% (1 SD) for in vivo TLD
measurements of patients over a 7 year period (Kalef-Ezra et al., 2002).
1.3.3 Semiconductor diodes
Diodes have been widely accepted in medical dosimetry because they are
robust and relatively simple to operate. They also offer the advantages of
high sensitivity, and immediate read-out. Silicon diodes are available as ei-
ther “p-type” or “n-type” depending on their minority charge carriers. There
seems to be a trend to favor p-type diodes, although recent studies contest
2See chapter 2 for a definition of Zeff and tissue equivalence issues.
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their advantages over n-type diodes in terms of dose-rate dependence and
resistance to radiation damage (Jornet et al., 2000; Saini and Zhu, 2004).
In in vivo dosimetry, diodes are commonly used for entrance and exit dose
measurements. The sensitivity of the diode detector depends on the lifetime
of the charge carriers and will decrease with accumulated dose (Jursinic,
2001; Rikner and Grusell, 1987). This reaction to radiation damage is the
main limitation of silicon diodes. Other factors to be considered are their
energy dependence (ZSi =14), dose rate dependence (Wilkins et al., 1997)
and temperature dependence (Rikner and Grusell, 1987). Because of these
dependencies, several correction factors have to be applied to the diode signal
(Meiler and Podgorsak, 1997). Diodes also suffer from angular dependence,
and one recent study recommends to limit the angles of incidence of the beam
to no more than ± 45 degrees in electron beams (Marre and Marinello, 2004).
It is generally agreed that diodes have a higher precision than TLDs (Loncol
et al., 1996). However, there seems to be no consensus on the achievable in
vivo accuracy: many studies report an accuracy below 3 % (1SD) (Jursinic,
2001; Essers and Mijnheer, 1999), but other researchers quote accuracies
around 10% (Alecu and Alecu, 1999). In particular, Higgins et al. (2003)
used diodes for IMRT quality assurance, and found deviations up to 16%
for individual field measurements. The same authors suggest that an accu-
racy of ± 10% at best should be expected for IMRT measurements. These
discrepancies can be explained by the fact that entrance dose measurements
depend critically on accurate calibration factors. Indeed, a surface diode is
exposed to a different spectrum than a detector positioned at depth. This
effect can be minimized if a thick build-up cap is used to achieve electron
equilibrium, but as a result the dose delivered to the target volume under
the diode will be decreased. Heukelom et al. (1991) insist on the necessity
of accurate calibration factors, and the need for frequent re-calibration for
good agreement with ion chamber measurements. It is likely that in vivo
diode measurements could achieve a higher accuracy if performed at depth.
New diodes are being developed for insertion in the patient (especially for
IMRT measurements), however no clinical studies are available at this time.
Perhaps the great advantage of diodes over TLDs is their relative ease of use
and time saving potential: no annealing procedure is necessary, calibration
is less frequent, and the dose estimate is available almost immediately.
1.3.4 2D techniques
Though this review concerns mainly point dosimeters, 2D in vivo dosimetry
techniques such as radiographic film, or Electronic Portal Imaging Devices
(EPIDs) need to be mentioned for the sake of completeness. These detectors
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give a measure of the transmission dose through the patient (see position
(d) in figure 1.1). The obvious advantage of these dosimeters is that they
can be used to record the dose across the whole field. The response of ra-
diographic (AgH) films tends to vary with depth and field size due to an
over-response to low energy photons (Khan, 1992). Few solid references are
available for the adequate handling of radiographic films in in vivo dosimetry,
but some national recommendations for film dosimetry are being processed
(TG69, 2005). Radiochromic films change color after irradiation and do not
need chemical processing. Their response is however still dependent on many
parameters (such as emulsion differences between film batches and post irra-
diation conditions). Hence, the handling conditions can be quite elaborate if
high accuracy is desired (Butson et al., 2003; Ciocca et al., 2003). EPIDs are
commonly used as an imaging device, to verify the patient’s position before
treatment. EPID dosimetry, though, is a relatively new field. TG58 (2001)
quote an achievable accuracy below 5% but advise caution due to quality
control and calibration issues.
1.4 Novel dosimetry techniques
Several novel approaches have been reported in the literature, and the most
significant are reported in this section. In general, they are still in the de-
velopment stage and therefore not used clinically (except in very few institu-
tions).
1.4.1 MOSFETs
Metal oxide semiconductor field-effect transistors (MOSFETs) are commer-
cially available and offer the advantages of instant read-out, extremely small
size, and permanent storage of the dose (Soubra et al., 1994; Butson et al.,
1996; Rosenfeld, 2002). In spite of this, their clinical application has been
limited, probably because of their angular dependence, their change of sen-
sitivity with use, and their relatively short lifetime (Ramani et al., 1997;
Peet and Pryor, 1999; Scalchi and Francescon, 1998). It has to be noted
that some recent improvements have fixed most of the reported problems for
MOSFETs (Cheung et al., 2004; Ramasehan et al., 2004) and new formats
(“micro-MOSFETs”, 2D-array) renewed the interest in MOSFETs for medical
dosimetry. New studies (Dong et al., 2002), (Rowbottom and Jaffray, 2004)
testify to their potential in radiotherapy and diagnostic imaging. However,
the precision is still lower than for diodes, resulting in a higher uncertainty
on the dose determination (Jornet et al., 2004) (precision 0.7% 1SD for MOS-
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FETs and 0.05% for diodes). MOSFETs have a very high spatial resolution
(Kron et al., 2002), making them suitable for small field measurements like
IMRT: Chuang et al. (2002) quote an agreement within 5% of TPS dose for
MOSFETs for a phantom verification of an IMRT treatment. Ramasehan
et al. (2004) conclude that an accuracy of 5% in in vivo dosimetry is possi-
ble, but warn of the necessity to wait 2 minutes between read outs because
of the so-called creep-up effect: this is not a problem for conventional radia-
tion therapy, but prevents the use of MOSFETs if individual field doses are
desired in IMRT.
1.4.2 Diamond detectors
The use of synthetic diamonds as in vivo radiation detectors has been re-
ported as early as 1987 (Nam et al., 1987). Diamonds have been considered
suitable for clinical purposes because of their small size and good tissue equiv-
alence. They are also resistant to radiation damage. However, their use for in
vivo dosimetry can be impaired by their dose-rate dependence and the need
for pre-irradiation (Laub et al., 1999; Hoban et al., 1994; Bucciolini et al.,
2003). Diamond detectors exhibit high sensitivity and high resolution (with
a sensitive volume of 1 mm3), but their advantage over diodes is debated
(Heydarian et al., 1993) except in very small fields (Heydarian et al., 1996).
Diamond detectors also have less angular dependence than diodes in electron
beams (Bjork et al., 2000). Laub and Wong (2003) demonstrated the need of
a small dosimeter for small IMRT fields, and recommend the use of diamond
detectors, TLDs or water equivalent scintillators. Bucciolini et al. (2003)
compared diamond detectors to diodes and ionization chambers, and con-
cluded that in spite of their positive characteristics, diamonds did not offer a
significant advantage over diodes in photon beams in conventional radiation
therapy.
1.4.3 Optical fiber dosimetry
Plastic scintillators Plastic scintillator systems also offer excellent tissue
equivalence, but their present design makes it difficult to subtract the noise
signal produced in the light-guide (Cerenkov radiation and fluorescence) from
the signal originating from the actual plastic scintillator chip (Beddar et al.,
1992a,b). Several approaches have been reported to improve the signal-to-
noise ratio. One approach consists in adding a “blank” optical fiber for sub-
traction of the light-guide signal: this can compromise the size of the optical
fiber bundle (Beddar et al., 1992c) and make the scintillator probe too bulky
to be inserted in a patient. Another approach is the optimization of the
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coupling between the fiber and the scintillator which, so far, has only had
a limited success in reducing the influence of the noise signal from the light
guide (Beddar et al., 2003, 2004). Plastic scintillation dosimetry may benefit
from a renewed interest if this problem gets solved.
Optically stimulated luminescence Optically stimulated luminescence
(OSL, see chapter 2) is related to thermoluminescence, but uses light (e.g.,
from a laser) instead of heat as the stimulation source. Huston et al. (2001)
described an OSL system for radiation therapy that uses two light guides
(one for the laser light, the other for the signal) and copper-doped glass as
the detector. This system demonstrated a very high sensitivity, dynamic
range, and stability (Huston et al., 2001), no dose rate dependence, and little
energy dependence (Huston et al., 2002). Though promising, this system has
not been applied in internal in vivo dosimetry to date. OSL signals from
aluminum oxide doped with carbon (Al2O3:C ) were also investigated by a
group in Orsay, France: the system consists of a relatively large pellet of
Al2O3:C (4 to 10 mm in diameter) and two light guides (Roy et al., 1997).
Few results have been reported from this system, which seems to be designed
for radioprotection dosimetry more than in vivo radiotherapy applications.
1.5 Practical issues: time and money
The ideal in vivo dosimetry system should:
 have a high accuracy
 be safe (no electronics/high voltage close to the patient)
 have a small size
 have no or few dependencies on beam parameters
 provide the absorbed dose in real-time
 be comprehensive (able to function in both photon and electron beams)
 be easy to use and calibrate
 be affordable
Table 1.1 summarizes the principal characteristics of the in vivo dosime-
ters mentioned in the previous section and figure 1.3 illustrates their re-
spective size. Overall accuracy is not the only requirement of a useful in
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vivo dosimeter: indeed, the spread of in vivo dosimetry has been limited
by practical issues, such as cost and time. Acquisition costs vary greatly
among dosimetry systems, and so does the amount of time the physicist (or
other person in charge) spends preparing and calibrating the system. Essers
and Mijnheer (1999) report that the total time invested for a comprehensive
in vivo dosimetry program with diodes in conformal radiotherapy is about
1.5 day/week, or 0.3 full-time equivalent (for two measurements per patient,
three patients per week). Calibration is quicker for TLDs (there are fewer
calibration factors), but the overall time spent for patient measurements is
longer. Essers and Mijnheer (1999) conclude than a diode program would
be cheaper than TLDs for most institutions. Diodes are an extremely conve-
nient tool for quality assurance dosimetry, and most clinical institution have
some experience using them. Hence, the time and skill investments needed to
transfer that knowledge to in vivo dosimetry is greatly reduced compared to
the acceptance of new dosimetry techniques, such as MOSFETs or diamond
detectors. As far as acquisition costs are concerned, a diamond detector sys-
tem is generally considered expensive (Bucciolini et al., 2003). The relatively
low lifetime of MOSFETs could also make them an expensive dosimetry sys-
tem in the long run. The time involved in calibrating these systems can not
be evaluated before their characteristics are better defined.
1.6 This thesis
The work summarized in this PhD thesis describes the development of a new
real-time dosimetry system for in vivo dosimetry and its applications in ra-
diotherapy and mammography. The intent was to develop a point dosimeter
which would be highly accurate and would offer real-time information about
the dose delivered to the point of measurement. This approach uses optical
fibers and the OSL from Al2O3:C but differs from the systems described in
section 1.4.3 in several critical aspects: its size, its sensitivity and the use of
the radioluminescence (RL) signal emitted by Al2O3:C during irradiation.
Chapter 2 describes the physical principles behind RL and OSL, and
investigates the characteristics of Al2O3:C as a tissue-equivalent dosimeter.
Chapter 3 deals with instrumentation features, as well as the methods de-
veloped to obtain reliable absorbed dose assessments from the RL and OSL
signals. Chapter 4 presents the response of the RL/OSL dosimeter in relation
to beam parameters: the reproducibility, linearity, energy dependence, etc of
the system will be detailed there. Chapters 5 and 6 present the application
of the RL/OSL dosimeter and the results of the first patient measurements
in radiotherapy and in mammography, respectively. In addition, chapter 6
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Figure 1.3: Several commonly used point dosimeters, their size and sensitive volume (SV)
or sensitive area (SA).
investigates the influence of the design of the RL/OSL probes with Monte
Carlo simulations.
During the course of this thesis work, the following articles have been
produced:
1. Aznar MC, Nathan R, Murray AS and Bøtter-Jensen L (2003) Deter-
mination of differential dose rates in a mixed beta and gamma field
using shielded Al2O3:C : results of Monte Carlo modelling. Radiation
Measurements vol.37 (4-5), pp 329-334.
2. Aznar MC, Andersen CE, Bøtter-Jensen L, Back SAJ, Mattsson S,
Kjaer-Kristoffersen F and Medin J (2004) Real-time optical-fibre lumi-
nescence dosimetry for radiotherapy. Physics in Medicine and Biology
vol.49, pp 1655-1669.
3. Aznar MC, Hemdal B, Medin J, Marckmann CJ, Andersen CE, Bøtter-
Jensen L, Andersson I, Mattsson S. In vivo absorbed dose measure-
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ments in mammography using a new real-time luminescence technique.
British Journal of Radiology. In Press.
4. Aznar MC, Medin J, Hemdal B, Thilander Klang A, Bøtter-Jensen, L,
Mattsson S. A Monte Carlo study of the energy dependence of Al2O3:C
crystals for real-time in vivo dosimetry in mammography. Radiation
Protection Dosimetry. In Press.
5. Andersen CE, Aznar MC, Bøtter-Jensen L, Back SAJ, Mattsson S and
Medin J (2003) Development of optical fibre luminescent techniques
for real-time in vivo dosimetry in radiotherapy. Standards and code of
practice in medical radiation dosimetry : Proc. Int. Symp. Vienna,
IAEA (2002), vol. 2 pp 353-360.
6. Marckmann CJ, Aznar MC, Andersen CE and Bøtter-Jensen L. Influ-
ence of the stem effect on radioluminescence signals from optical fiber
Al2O3:C dosemeters. Radiation Protection Dosimetry. In Press.
7. Andersen CE, Marckmann CJ, Aznar MC, Bøtter-Jensen L, Kjær-
Kristoffersen F and Medin J. An algorithm for real-time in vivo dose-
rate measurements using the radioluminescence signal from Al2O3:C .
Radiation Protection Dosimetry. In Press.
8. Marckmann CJ, Andersen CE, Aznar MC and Bøtter-Jensen L. Novel
optical fiber dosimeter systems for clinical applications based on radi-
oluminescence and optically stimulated luminescence from Al2O3:C .
Radiation Protection Dosimetry. In Press.
9. Edmund JM, Andersen CE, Marckmann CJ, Aznar MC, Akselrod MS
and Bøtter-Jensen, L. An optimized CW-OSL measurement protocol
using optical fibre Al2O3:C dosimeters. Radiation Protection Dosime-
try. In Press.
10. Buckley L, Rogers, DWO, Aznar M and Medin J. Monte Carlo calcu-
lated dose to Al2O3 per unit dose to water in photon beams compared
to measured OSL response per unit dose to water. Presentation at the
AAPM annual meeting, Pittsburgh PA July 2004.
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2 Luminescence dosimetry
with Al2O3:C
Before describing the RL/OSL dosimetry system based on Al2O3:C which is
the topic of this thesis, it is necessary to consider in some detail the characte-
ristics of Al2O3:C, first as a luminescent material, and secondly as a potential
in vivo dosimeter. In the next section, the unique luminescence characteris-
tics of Al2O3:C are described, with an emphasis on its use in real-time optical
fiber dosimetry. Subsequently, the physical quantities and units which will
be used in this work are defined and some theoretical considerations of the
interaction of radiation with Al2O3:C are provided.
2.1 Principles of luminescence
2.1.1 Band gap theory
The different processes by which non-thermal energy transforms into light
are grouped under the term luminescence. When certain materials with
a crystalline structure are exposed to ionizing radiation, luminescence can
arise from either thermal or optical stimulation. The overall process can be
broken down in three steps:
1. ionization due to exposure of the crystal to radiation
2. storage of radiation energy
3. stimulation
. In a solid, where atoms are closely bound together, electrons populate
bands of allowed energy states, separated by “forbidden” bands. The “band
gap” is defined as the forbidden energy band between the two outermost
allowed bands in a solid, namely, the conduction band and the valence band.
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The valence band is the lower band of allowed energy states, and is usually
filled with electrons. In the band gap model, absorption of energy (e.g.,
from ionizing radiation) in a crystalline structure results in the creation of
electron-hole pairs: if sufficient energy is provided to an electron to break
from the valence band and overcome the band gap, this electron is moved to
the conduction band, where it can move freely about the crystal (see figure
2.1). The deficit of negative charge in the valence band creates a “hole”.
The width of the band gap depends on the material considered: luminescent
materials have a wide band gap (e.g., around 9 eV for Al2O3:C (Akselrod
et al., 1998)). Once in the conduction band, the electron quickly loses its
excitation energy and can either
 fall back to the valence band immediately and recombine with a hole
 or get trapped at defects within the crystalline structure
. Traps are defined as crystal defects which are able to capture a charge
carrier (electron or hole) and release it to its original band. Some particular
defects that can hold both electrons and holes are referred to as “recombi-
nation centers”. A trapped electron will remain so until it is provided with
enough stimulation energy to overcome the trap and eventually recombine
with a hole at a recombination center. These recombinations can result in the
emission of light, i.e. luminescence. Several factors compete with the produc-
tion processes: some hole traps are classified as non-radiative recombination
centers (a hole-electron recombination in those traps won’t lead to emission
of light). Similarly some electron traps are not responsive to stimulation by
light and won’t easily release their trapped electrons: they are referred to
as “optically deep traps”. “Shallow traps” on the other hand are unstable at
ambient temperature, and may release their trapped electrons even without
external stimulation. In general, radiative processes which happen during the
exposure of the crystal to radiation are classified as “prompt luminescence”
or radioluminescence, “RL”. In case of an emission during stimulation, this
phenomenon is referred to as “optically stimulated luminescence” or “ther-
moluminescence” depending on whether the stimulation source is light or
heat. The presence of shallow, deep traps, as well as non-radiative traps are
grouped under the term “competing processes”, because they interfere with
the type of luminescence which is of dosimetric interest. The luminescence
emitted by Al2O3:C crystals is characteristics of the oxygen vacancy centers
introduced by the presence of carbon impurities (in concentrations up to 5000
ppm). The occupancy of an oxygen vacancy center by two electrons gives rise
to a neutral “F” center, whereas occupancy by one electron forms a positively
charged “F+” center. The main luminescence emission occurs around 420 nm
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and is believed to be caused by:
F+ + e→ F ∗ → F + hν (2.1)
where F∗ is an excited F center, which decays to the ground state with the
emission of a photon at 420 nm (Yukihara et al., 2003). The process is
associated with a relaxation time of approximately 35 ms.
2.1.2 Uses of Al2O3:C in non-medical dosimetry
During the last 20 years, OSL techniques have been successfully applied to
environmental dosimetry (Huntley et al., 1985; Bøtter-Jensen, 1995; Bøtter-
Jensen et al., 1997), now widely replacing thermoluminescence (TL) methods.
The advantages of OSL over TL are, among others, an increased sensitivity,
fast reading, the possibility of making repeated read-outs and the absence of
heating processes. The materials used in environmental dosimetry are mostly
quartz and feldspars because of their abundance in soils. Al2O3 appeared on
the thermoluminescence dosimetry scene in the mid-50ies, but its sensitivity
was too low for uses in environmental dosimetry. The dosimetric properties
of pure Al2O3 were improved significantly by introducing oxygen vacancies
under strong reducing conditions and in the presence of graphite: TL mea-
surements with Al2O3:C single crystals were first reported by Akselrod et al.
(1990). Single crystals are grown as rods of varying diameters (down to 200
mm). The most interesting features of Al2O3:C are its excellent OSL sensi-
tivity, reproducibility and linearity. Bøtter-Jensen et al. (1997) showed that
the OSL detection limit of standard Al2O3:C chips (5 mm diameter and 1
mm thickness) is below 1 mGy. The response of OSL is linear with dose over
a very large range (0.05-50 Gy), as demonstrated by McKeever et al. (1996)
and Polf et al. (2002). Al2O3:C detectors have been used in personal dosime-
try for over 50 years and are commercialized by Landauer Inc. (Chicago,
USA). As part of this project, the response of Al2O3:C to gamma and beta
radiation from the soil was studied, in order to investigate the potential of an
RL/OSL optical fiber dosimeter in environmental dosimetry (Aznar et al.,
2003).
2.2 OSL from Al2O3:C
When the crystal is stimulated by light to produce OSL, the resulting signal
starts at a high value and decreases with time. The depletion of the signal
as stimulation continues indicates that the supply of electrons from the OSL
traps is becoming exhausted. As seen with the band gap model, the OSL
Risø-PhD-12(EN)
20 Luminescence dosimetry with Al2O3:C
(2
)
va
le
n
ce
 b
a
n
d
co
n
d
u
ct
io
n
 b
a
n
d
(1
)
(3
)
γ
, 
e
R
C
va
le
n
ce
 b
a
n
d
co
n
d
u
ct
io
n
 b
a
n
d
γ
, e
R
C
*
(b
) 
O
S
L
(a
) 
R
L
*
e
le
ct
ro
n
h
o
le
F
ig
ur
e
2.
1:
B
an
d
ga
p
th
eo
ry
:
pr
om
pt
lu
m
in
es
ce
nc
e
or
“R
L
”
(a
)
an
d
st
im
ul
at
ed
lu
m
in
es
ce
nc
e
e.
g.
“O
SL
”
(b
).
R
C
:r
ec
om
bi
na
ti
on
ce
nt
er
.
*:
ex
ci
te
d
st
at
e
of
th
e
re
co
m
bi
na
ti
on
ce
nt
er
.
(1
)
O
SL
tr
ap
,
(2
)
sh
al
lo
w
tr
ap
,(
3)
de
ep
tr
ap
.
Risø-PhD-12(EN)
2.2 OSL from Al2O3:C 21
signal will depend on several factors, such as the number of traps, their
capacity to release a charge carrier under stimulation (referred to as the
“photoionization cross section”), the number of electrons in the traps after the
end of the exposure. It will also depend on the wavelength of the stimulation
(related to how much energy is imparted to the trapped electrons). These
parameters and their influence on the rate and the shape of the OSL decay
curve are discussed in this section. Theoretical models have been developed
in great detail to describe the complex phenomena involved in OSL1, and only
a brief review will be given here. This model is based on several assumptions:
there is only one type of electron trap and one type of recombination center,
all charge transport takes place via the conduction band, etc. The OSL
intensity can be described as:
IOSL = −η·dm
dt
(2.2)
where η is the luminescence efficiency (η=1 if all the recombinations are
radiative) and m is the concentration of trapped holes. If we assume that
the crystal is in quasi-equilibrium (no free electrons in the conduction band)
and we have charge neutrality in the crystal, then dm/dt = dn/dt (where n
is the concentration of trapped electrons), and equation 2.2 becomes:
IOSL = −dn
dt
(2.3)
On another hand, if we assume that there is no retrapping (all ejected elec-
trons will lead to radiative recombinations), then we can write:
IOSL = n·σ(λ)·φ(λ) (2.4)
where φ is the intensity of optical stimulation and σ is the photoionization
cross section. Combining equations 2.2 and 2.4 shows that the OSL signal
can be described as an exponential decay, such as:
IOSL = IOSL0·exp(−
t
τ
) (2.5)
where τ=σ(λ)·φ(λ)−1 and can be seen as a lifetime. This model is referred to
as the “one trap-one center model”: if several traps are considered, the OSL
signal will be a sum of several exponentials, depending on the specific ioniza-
tion cross section of each type of traps. However, the presence of competing
1A more complete discussion of OSL mathematical models is provided in the book
“Optically stimulated luminescence dosimetry”by L. Bøtter-Jensen, S.W.S. McKeever and
A.G. Wintle, (Elsevier Science, Amsterdam, 2003).
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processes (e.g., deep traps) is going to disturb these exponential relation-
ships. It can be shown that the one trap model can be expanded to account
for shallow and deep traps in the following fashion:
IOSL = IOSL0·exp(−
t
τ
) + a1·exp(− E
kT
)− a2(t) (2.6)
where the term following a1 describes the action of shallow traps (E being
the trap depth, T the temperature, and k the Boltzmann constant), and
a2(t) describes the time dependent influence of deep traps. These two terms
give rise to a very slow, temperature dependent component in the OSL decay
curve. The shape of the OSL decay will vary according to the relative dis-
tribution of OSL traps with respect to deep and shallow traps in the crystal
(which is determined partly by the growth conditions). As a result, some
OSL signals decay in an exponential fashion, while some others will display
a more complex pattern.
2.3 RL from Al2O3:C
RL is produced continuously when the material is irradiated and information
about the irradiation can be obtained in real-time. The different components
of the RL signal are illustrated in figure 2.2. At the beginning of the irradi-
ation, a “slow-rise” phenomenon can be observed. This is referred to as the
“transient”. As the crystal is being irradiated, the electrons transported to
the conduction band can either get trapped (OSL) or recombine promptly
(RL). As the OSL traps are being filled, they offer less competition to RL
recombinations. This produces a “sensitization” of the crystal (Erfurt and
Krbetschek, 2002), and thus the RL signal increases with irradiation time.
The signal eventually reaches a plateau (as observed by (Erfurt et al., 2000)).
However, absorbed doses relevant for medicine are too small to observe this
phenomenon, and the RL signal usually presents a continuous increase during
the irradiation. At the end of the irradiation, the signal does not immedi-
ately return to background level; this afterglow is caused by some charge
being released from the shallow traps, giving rise to phosphorescence.
2.4 Dosimetric considerations
2.4.1 Interaction of radiation with matter
When a photon beam (e.g., megavoltage x-rays) passes through an absorb-
ing medium (such as water or body tissue), some energy is transferred to
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Figure 2.2: Components of the RL signal for exposure at a constant dose rate. Top: the
whole RL signal from Al2O3:C for an absorbed dose of 1 Gy, (a) transient, (b) slope due
to sensitization, (c) afterglow. Bottom (e): after the end of the irradiation, some afterglow
is observed due to the presence of shallow traps.
the medium. The fraction of this energy which is eventually absorbed in the
medium can be used as a predictor of biological damage. The interaction of
photons with matter in the energy range used in radiation medicine is de-
scribed by three majors effects: the photoelectric effect, Compton incoherent
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scattering, and pair production. Their characteristics are very simply sum-
marized in figure 2.3. A fourth process, coherent (or Rayleigh) scattering
also takes place, but is much less prevalent at the energies considered in radi-
ation medicine. The relative occurrence of the different processes is usually
expressed in terms of cross-sections. The cross-section for a given event is
the number of events divided by the incoming fluence and has the dimen-
sion of area. For example, the attenuation undergone by a photon beam in
a medium of thickness ∆x is described by the linear attenuation coefficient
(ICRU, 1998), defined as:
µ =
number of photons interacting in ∆x
∆x
(2.7)
Most commonly, the attenuation characteristics of the medium are described
by the mass attenuation coefficient, µ/ρ. Since the absorption of energy is
related to the biological effect, the mass energy absorption coefficient is the
quantity of interest and can be calculated as:
µen/ρ = µ/ρ · E¯ab
hν
(2.8)
where E¯ab is the average energy absorbed per interaction, and hν is the
energy of the photon (ICRU, 1998). One fundamental quantity is the kerma
(kinetic energy released per unit mass). It is defined as:
K =
dEtr
dm
(2.9)
where dEtr is the sum of the initial kinetic energies of all the charged particles
(electrons and positrons) liberated by the uncharged particles (photons) in
a mass dm of material. The kerma is expressed in J.kg−1 or Gray (Gy)
The kerma concerns the initial transfer of energy to matter. However, the
quantity of interest in most dosimetric situations is the absorbed dose within
a certain volume, which is defined as:
D =
d²¯
dm
(2.10)
where d²¯ is the mean energy imparted to matter of mass dm. The unit of ab-
sorbed dose is also Gy. If certain conditions are respected (i.e., if charged par-
ticle equilibrium exists across the volume of interest and if radiative losses are
negligible), then equality between absorbed dose and kerma is approached.
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Figure 2.3: Characteristics of the major interaction processes: photoelectric effect, Comp-
ton scattering and pair production.
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2.4.2 Tissue equivalence
In order to be as accurate as possible, a dosimeter must respond to radia-
tion the same way body tissue would. This requirement is hard to satisfy
as was seen in chapter 1. For a closer look at tissue equivalence (and re-
sulting energy dependence), it is useful to know the respective proportion
of the interaction processes. Figure 2.4 compares the relative importance
of interaction processes for a wide range of energies. Because of the higher
effective atomic number of Al2O3, the photoelectric effect is dominant for a
wider range of energies than for water. At low energies (10-20 keV), it is
clearly dominating all other interaction processes. Also the pair production
process (which is strongly dependent on Z) is becoming significant for Al2O3
around 10 MeV (compared to around 30 MeV for water). This could have
an influence on the response of Al2O3 at high radiotherapy energies. A quick
way to estimate whether a material is tissue equivalent or not is to look at its
atomic number (Z). For composite materials (air, Al2O3), an approximative
value of the effective atomic number (Zeff) can be calculated according to
equation 2.11 (Johns and Cunningham, 1983).
Zeff =
m
√
a1Z
m
1 + a2Z
m
2 + . . . (2.11)
In the radiotherapy energy range, the Compton effect is the predominant
mode of interaction: since the cross section for the Compton effect depends
on Z, m = 1. For Al2O3, this results in Zeff = 10.2 compared to 7.5 for tissue.
In the diagnostic energy range however, the photoelectric effect, whose cross
section depends on approximately the fourth power of Z, is predominant. It
is recommended to use 3.4< m <3.8 (Johns and Cunningham, 1983), lead-
ing to Zeff = 11.4 for Al2O3. These results indicate that Al2O3 is not tissue
equivalent. The tissue equivalence of a material can also be investigated
in detail by looking at the way radiation interacts with it over a range of
energies. In photon beams, this would imply looking at the mass energy
absorption coefficient, or rather at the ratio of the mass energy absorption
coefficients of the material of interest and a reference material (water for ra-
diation therapy, as the human body is close to water). The ratio of µen/ρ
of many materials with respect to water is presented in figure 2.5. Among
all those dosimetric materials, plastic (vinyltoluene) has the flattest energy
response, and graphite (i.e., diamond) is the closest to water. Al2O3 will un-
derestimate the dose (compared to water) for energies 0.3 to 3 MeV, but will
overestimate the dose to water outside of this range. However, this behavior
is less pronounced than for silicon. The interaction of charged particles (such
as electrons) is described by the mass stopping power (usually expressed in
MeV.cm2.g−1). Figure 2.6 shows that Al2O3 has a slightly flatter response
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Figure 2.4: Predominance of interaction processes: photoelectric effect (κ), Compton
scattering (σ), coherent scattering (σcoh), pair production (pin in a nuclear field, pie in an
electron field). Source: NIST (XCOM).
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Figure 2.6: Ratio of total stopping power to water for several dosimetric materials. Source:
NIST (ESTAR).
than silicon. In conclusion, it can be seen that Al2O3, though not as tissue
equivalent as graphite or plastic, should be more appropriate than silicon,
from a purely dosimetric point of view.
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2.4.3 Cavity theory: size matters
A last parameter to take into account when studying the tissue equivalence of
a detector is its size: indeed, a small detector will measure the absorbed dose
resulting from interactions in its own material, but also in the neighboring
medium. This is described by the “cavity theory”. A detector introduced in
water or in tissue is said to form a cavity in this medium. Cavity theory
attempts to define the relationships between the absorbed dose recorded by
the detector (Dcav) and the absorbed dose in the unperturbed medium in the
absence of the cavity (Dmed). A general cavity theory for photon beams has
been proposed by Burlin in 1966 (Burlin, 1966) and states that:
Dcav
Dmed
= dScav,med + (1− d)(µen
ρ
)cav,med (2.12)
where Scav,med is the ratio of mass collision stopping power of the medium to
the cavity, and (µen
ρ
)cav,med is the ratio of mass energy absorption coefficient
of the medium to the cavity averaged over the photon spectrum. d is a
weighting factor which describes the contribution to the total dose of electrons
generated by photon interactions in the medium, and (1-d) is the contribution
to the total dose from electrons generated in the cavity. If d→ 1, the equation
approaches the Bragg-Gray conditions, and the cavity is said to be small. On
the other hand, if d→ 0, the cavity is said to be large. Burlin made several
approximations to permit the simple calculation of d (the attenuation of the
electrons is exponential and the energy spectrum is not significantly changed
by the presence of the cavity), and concluded that d could be expressed as:
d =
1− exp(−βg)
βg
(2.13)
where β is the effective mass absorption coefficient and g is a factor related
to the size of the cavity. There have been many discussions in the literature
about the correct formulations for g and β, and there is no general agreement
(Burlin and Chan, 1969; Janssens et al., 1974; Paliwal and Almond, 1976).
It was however noted (Mobit, 1996; Miljanic and Ranogajec-Komor, 1996)
that the disagreement between those different formulations was less than 5%.
Hence, for the simple purposes of this discussion (i.e., characterize where the
size of the detectors position them in cavity theory) a simple approach will
be used where g (the pathlength of the electrons crossing the cavity) is given
by g = 4×volume/surface area and β is given by
exp(−βR) = 0.04 (2.14)
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This last formulation was suggested by Janssens et al. (1974), and R is the
extrapolated range of the electrons crossing the cavity. The same analysis is
used by Beddar et al. (1992b) in their work on plastic scintillators. Figure
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Figure 2.7: Parameter “d” from Burlin cavity theory versus electron energy for several
dosimeter sizes. Circles: 0.5 mm ø x 2 mm `. Triangles: 1 mm ø x 2 mm `. + : 0.3 mm
ø x 1 mm `. X : 0.1 mm ø x 0.5 mm `. The solid line represents the response of a plastic
scintillator (1 mm ø x 4 mm `).
2.7 shows parameter “d” as a function of electron energy for different dosime-
ter sizes, including a plastic scintillator (the smallest described by Beddar
et al. (1992b), 1 mm ø x 4 mm `). As can be seen, this scintillator has the
same behavior in terms of cavity theory as the largest aluminum oxide crystal
used in this work (0.5 mm ø x 2 mm `). Small cylinders of aluminum oxide
approach the small cavity approximation for radiotherapy energies (i.e., sec-
ondary electrons are generated in the medium outside the cavity), but will
form a large cavity at diagnostic energies. Based on figure 2.7 and equation
2.12, the following deductions can be made:
1) at low energies, where the photoelectric predominates and the parameter
d is low, the ratio Dcav/Dmed is dominated by the strong dependence of
the mass energy absorption coefficient on Z. Hence, Dcav/Dmed >> 1
for aluminum oxide.
2) at high energies, the Compton effect predominates and µen/ρ does not
vary much with Z. Moreover, the parameter d is larger and the final
results depends mostly on the stopping power ratio. In this context,
Dcav/Dmed approaches 1 for aluminum oxide crystals.
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This discussion gives some insight on the importance of the size of the detec-
tor, and its potential effect on its ability to estimate absorbed dose to water.
At low energies (such as encountered in mammography), small changes in d
can have a significant effect on the Dcav/Dmed ratio because of the strong
dependence on Z. Hence, for applications in mammography, it can crucial to
optimize the size of the detector in order to minimize its variation in response
with energy. In contrast, at radiotherapy energies, changing the size of the
detector will not have as dramatic an impact on energy response. However,
because of the increased requirement for accuracy in radiotherapy applica-
tions, even minor improvements in energy dependence could justify using
smaller detectors.
2.5 Summary
The properties of RL and OSL from Al2O3:C crystals have been reviewed.
The use of Al2O3:C in environmental and accident dosimetry means that a
large body of literature is available, and theoretical models have been devel-
oped to predict the behavior of the OSL signal. This forms a solid basis for
the investigation of the properties of Al2O3:C as a medical dosimeter. Some
theoretical dosimetry considerations have been developed in this chapter to
show that Al2O3:C crystals are suitable choice for in vivo radiation dosimetry.
Of particular interest for the next chapters are the following conclusions:
 The luminescence produced by Al2O3:C crystals can be classified as:
“prompt luminescence” or RL, and “luminescence under optical stimu-
lation” or OSL
 RL and OSL signals are influenced by competing processes, due to the
presence of deep and shallow traps in the crystalline structure: the OSL
signal does not follow a purely exponential decay, and the RL signal
exhibits an “afterglow” component
 Competition between RL and OSL traps gives rise to RL sensitivity
changes during the irradiation: the RL signal presents a linearly in-
creasing slope for exposure at a constant dose rate
 The decay of the luminescence-producing centers results in an emission
at 420 nm and has an associated lifetime of 35 ms
 The relatively high effective atomic number of Al2O3 (Zeff ∼ 10-11) is
still lower than that of silicon diodes (Zeff ∼ 14)
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 The small size of the crystals means that, at high energies, most of the
secondary electrons are generated in the medium outside the cavity
 The optimization of the size of Al2O3:C crystals is crucial for applica-
tions at low energies
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The RL/OSL optical fiber dosimeter system developed at Risø can be divided
into three major components: i) a sensor crystal, ii) an optical detection sys-
tem, and iii) the signal-processing electronics. The sensor Al2O3:C crystal is
connected to the optical system via a plastic fiber. To produce OSL, a green
laser beam is focused through a dichroic color beam splitter and transported
via the optical fiber into the Al2O3:C dosimeter. The OSL signal is then
transported back along the same fiber. The dosimeter system is controlled
using a standard laptop computer (Andersen et al., 2003a). This configura-
tion enables the system to be compact (40x30x10 cm3) and transportable.
This configuration uses only one optical fiber to reduce the size of the probe
inserted into a patient for in vivo dosimetry. Figure 3.1 is a schematic il-
lustration of the instrument, including the main electronic components. A
photograph of the whole system is shown in figure 3.2.
This chapter describes in more detail the components of the system, as
well as the analysis procedures developed to obtained reliable absorbed dose
assessments from the RL and OSL signals.
3.1 Overview of the system
In all experiments performed in the present work, the RL and OSL signals
were measured according to the protocol sketched in figure 3.3, using a 10
Hz sampling rate unless otherwise specified. As shown, the RL is collected
during irradiation, while the OSL is measured by switching the laser on after
the irradiation is completed. This approach allows the investigation of the
respective properties of the RL and the OSL signals. Other protocols have
been described by Polf et al. (2002) and Gaza et al. (2004), where the laser
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Figure 3.1: Schematic of the RL/OSL dosimetry system.
is switched on and off during the irradiation. However, this approach does
not enable the use of the RL signal for dose assessment.
The RL/OSL dosimetry system is controlled from a laptop computer
equipped with a Labview interface (National Instruments), as shown in figure
3.4. Two RL/OSL readers can be connected through a parallel interface and
thus controlled by a single computer as seen in figure 3.2. From there, the
laser can be switched on and off manually, or a program file can be created
to keep the laser on in a specific time window. Data are stored as ASCII
files and are later processed with the statistical software programme S-Plus
(Insightful Corporation, Seattle, USA).
3.2 Optics and electronics
The signals generated in the Al2O3:C crystal are carried through the fiber to
a fiber collimator which focuses the light onto a dichroic beam splitter. This
dichroic beam splitter (Delta BSP 480) reflects more than 99% of the 390-
425 nm bandwidth. This range includes the wavelength of the luminescence
signals. From the beam splitter, the luminescence signal passes through
a lens focusing the light through a filter pack consisting of three 3.5 mm
thick band pass filters (BP25-395440 with band pass from 395-440 nm) and
onto a Perkin-Elmer photomultiplier tube (CP-982). The PMT was selected
Risø-PhD-12(EN)
3.2 Optics and electronics 35
Figure 3.2: Photograph of the RL/OSL dosimetry system, showing a configuration where
two measurement probes can be used simultaneously.
for its low dark count signal (3-5 counts per second) and almost constant
response from 200 to 650 nm. To generate the OSL, a green laser (Laser2000,
frequency doubled YAG laser, 532 nm, 20 mW) is transmitted through the
beam splitter (transmitting 500-700 nm with more than 90% throughput) and
coupled into the fiber dosimeter through the collimator. After interaction
with the Al2O3:C crystal, the OSL signal is transmitted back through the
fiber together with some of the laser light reflected from the fiber-crystal
interface and from the facets of the crystal. The laser light reflected by
the beam splitter is subsequently sufficiently reduced by the filter pack in
front of the PMT. Thus, only luminescence is transmitted to the PMT. The
filter combination was designed to yield a high signal to noise ratio (S/N)
between the RL signal from the dosimeter Al2O3:C crystal and the noise
signal generated in the fiber (see section 3.3.2). The whole system is made
light-tight, thus preventing blinding of the PMT from ambient light sources
and reducing the background noise level. A PC program made in Labview
controls the system through a National Instruments 6036 PCMCIA card.
The system is able to record data at 5 kHz sampling rate.
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Figure 3.3: RL and OSL signals from Al2O3:C for an absorbed dose of 1 Gy.
3.3 The optical fibers
3.3.1 PMMA fibers
Most optical fiber dosimeters described in the literature use pure silica fibers
(Beddar et al., 1992b; Huston et al., 2001). In this project however, it was
decided to use plastic fibers (based on polymethylmethacrylate or PMMA)
because of their increased flexibility and reduced cost compared to silica
fibers. The PMMA fibers vary slightly depending on the size of the detector
crystal considered. A description of every “fiber+crystal” assembly used in
this project is given in table 3.1.
Super Eska SK-40 (Mitsubishi Rayon Co., LTD., Japan) optical fibers are
made of a 1 mm PMMA core. The total diameter of the fibers, including
cladding and jacket, is 2.2 mm (see figure 3.5). In the first probe prototype
that was designed at the beginning of this project, no adhesive was used
between the crystal and the fiber. Instead, the crystal was held close to the
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Figure 3.4: User interface of the RL/OSL dosimetry system.
Table 3.1: Fibers and crystals used in this work
Fiber Total Characteristics Crystal Crystal Adhesive
number diameter origin size (mm)
01 2.2 mm Super Eska SK-40 pellet 1x1x2 none
43 2.2 mm Super Eska SK-40 pellet 1x1x2 NOA 61
48 1 mm GH-2001-P growth 52 0.48 ø x 1 ` NOA 61
49 1 mm GH-2001-P growth 52 0.48 ø x 1 ` NOA 61
40B 2.2 mm GH-4001-P pellet 0.9x0.9x2.6 NOA 61
37 1 mm GH-2001-P growth 60 0.48 ø x 3 ` NOA 61
fiber extremity by a “shrinkflex wrapping”. Though this method provided a
satisfactory sensitivity, it resulted in a rather bulky probe (see figure 3.5).
Hence, a new method was developed using NOA 61 as an UV curable optical
adhesive (Polf et al., 2002; Marckmann et al., 2005). In order to protect the
probe against the harsh hospital environment (tight bends in catheters and
humid environment), a jacket made from Araldite is cast around the exposed
crystal and fiber area. According to this technique, fiber 01 was reworked to
become fiber 43 in August 2003. Similarly, new probes were developed using
small crystals and GH-2001-P fibers (also from Mitsubishi Rayon Co., LTD.).
The resulting probe has a total diameter of only 1 mm. In all fibers, the fiber
end not connected to the crystal is fitted with an SMA fiber connector. The
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choice of SMA connectors was made because FC connectors for multimode
fibers with a core/cladding diameter above 125 µm were not available.
Figure 3.5: Photograph of the large RL/OSL fiber. Top: fiber 01, with shrinkflex wrap-
ping. Bottom: fiber 43 using NOA 61 adhesive and an Araldite coating.
3.3.2 Signal coming from the light guide
The signal generated by ionizing radiation in the optical fiber during exposure
introduces a noise component in all real-time measurements. Extensive lit-
erature attests to the presence of this so-called “stem-effect” in optical-fiber
dosimeters using both plastic and silica fibers (de Boer et al., 1993; Clift
et al., 2000). Beddar et al. (1992a) analyzed the effect of noise in plastic
scintillator measurements (using pure silica fibers) and concluded that the
main contributor was Cerenkov radiation. Cerenkov radiation is generated
in a dielectric medium when a charged particle with a velocity greater than
that of light in the medium is passing through the medium. The Cerenkov
light is generated in an angle Θ defined as
cosΘ =
1
βn
(3.1)
where β is the ratio of the charged particle velocity to the speed of light in the
medium, and n is the refractive index of the medium. For the PMMA fibers
used in this project, it has been shown that the main contribution to the stem
effect is not from Cerenkov light, but from fluorescence (see (Marckmann
et al., 2005) for more detail). As a result, the signal generated in the optical
fiber is constant regardless of the angle of incidence of the radiation beam.
In the case of the RL/OSL system, this signal will be present when the RL
signal is collected. The OSL is collected after the irradiation is completed
and is not affected by the noise signal from the fiber. Simple measurements
were performed in a solid water phantom with fiber 43 to assess the order of
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magnitude of the noise signal. For electron beams (from 6 to 22 MeV), the
stem effect represents between 1 and 2% of the RL signal generated by this
particular crystal. The effect is larger for photon beams, and can reach 4%.
These estimates, however, are only valid for measurements in a conventional
radiotherapy set-up, where the detector is positioned at the center of the
beam. The impact of the stem effect turns out to be more critical for IMRT-
type measurements. Indeed, due to the nature of an IMRT treatment plan,
many small fields are used, “sweeping” over the target volume. Inevitably,
there will be some instances where the detector lies outside the beam and only
the fiber is irradiated. Consequently, the uncertainty on the dose estimate
due to the presence of stem effect is likely to be much larger. Hence, it is
crucial to discriminate the real RL signal from the noise signal if a reliable
absorbed dose assessment is to be achieved. A method using temporal gating
of the signals will be detailed in section 3.6.3.
3.4 Crystals
Three different Al2O3:C crystals were used in this work, as summarized in
table 3.1. All crystals were manufactured by Landauer Inc, Chicago, USA
and were grown according to the Stepanov method and Laser Heated Pedestal
Growth (LHPG) method. The crystal in fibers 01 and 43 was cut from a
standard Al2O3:C pellet (5 mm in diameter and 1 mm in thickness, used for
environmental dosimetry at Risø) to obtain a 1x1x2 mm3 crystal.
Smaller crystals were grown as a 0.48 mm diameter rod by Landauer
Ince˙specially for this project. This rod was referred to as growth #52 and
was cut into 2 mm long segments, resulting in crystals #52-1 and #52-2.
These crystals were annealed to 900 degrees Celsius, then exposed to a high
dose of radiation (to fill all traps), and bleached with UV light (to free the
dosimetric traps) before being used as dosimeters. As mentioned in chapter
2, different crystals have different luminescence characteristics. The signals
from three fibers used in this project and simultaneously irradiated in a
small beta source at Risø are displayed in figure 3.6. It can be observed that
fiber 43 exhibits higher RL and OSL signals because of its larger crystal.
In terms of luminescence signal per gram of crystal, however, fibers 48 and
49 are actually more sensitive. Fiber 43 also shows a slower OSL decay
and experiences an increased RL sensitization compared to the other fibers.
The apparent difference in sensitivity between fibers 48 and 49 is caused by
differences in optical coupling or in the sensitivity of the photon counting
systems.
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Figure 3.6: Signal from three different Al2O3:C fibers for an absorbed dose of approxi-
mately 2 Gy, delivered at 3 Gy/s: RL (top row) and OSL (bottom row). Fiber 43 exhibits
the highest sensitivity, the most RL sensitization and the slowest OSL decay.
3.5 Analysis of the OSL signal
The depletion rate is a crucial parameter, since in theory all traps should be
emptied in order to “reset” the OSL signal to zero and prepare the crystal
for a new measurement. The dose absorbed by the detector is proportional
to the intensity of the OSL signal and, in principle, a dose estimate can
be obtained within a few seconds by reading the initial value of the OSL
decay curve. However, for high precision, it is necessary to integrate the
OSL decay curve and subtract the background noise caused by e.g. scattered
laser light. Indeed, a dose estimate obtained by looking only at the “initial”
value of the decay curve is susceptible to uncertainties due to variations of the
laser output, for example. As a result, a long integration time could reduce
the significance of these fluctuations and lead to increased precision of the
dose estimate. On another hand, the influence of the competing (deep and
shallow) traps increases with longer integration times. A compromise must
be found between these two effects, and this can only come from experience
with a specific crystal. Figures 3.7 and 3.8 illustrate this issue in the case of
fiber 48. The crystal was irradiated in the small beta source and was exposed
to five different doses between 0.5 and 4 Gy. This process was repeated 5
times. It can be observed that a significant improvement in the linearity of
the dose response can be obtained by integrating the OSL signal for more
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than 20 seconds. However, figure 3.7 indicates that the overall reproducibility
of the dose assessment can be degraded by integrating for too long. As a
compromise between these two competing effects, the OSL signal should be
integrated for 100 seconds. This value was found to be optimal for all the
crystals used in this work.
0.90
0.95
1.00
1.05
1.10
1.15
000 s 001 s 010 s
020 s 050 s
0.90
0.95
1.00
1.05
1.10
1.15
100 s
0.90
0.95
1.00
1.05
1.10
1.15
400 s 500 s 700 s
Dose [Gy]
N
o
rm
a
li
z
e
d
 O
S
L
 r
e
s
p
o
n
s
e
 [
O
S
L
 p
r.
 d
o
s
e
 u
n
it
]
1 2 3 4 1 2 3 4
1 2 3 4
1SD = 8.74 % 8.2 % 5.73 %
4.11 % 1.31 % 0.494 %
0.996 % 1.15 % 1.33 %
Figure 3.7: Reproducibility of the OSL response depending on the integration time. The
OSL signal is integrated for durations ranging from 0s (using only the“initial”OSL reading)
to 700 s, and the results are plotted as OSL response per dose unit (absorbed doses ranged
from 0.7 to 4 Gy). The standard deviation of the results is given for each integration time.
Integrating for 100 s gives the flattest response of the OSL signal per dose unit.
3.6 Analysis of the RL signal
Because the sensitization effect is the result of competition between RL and
OSL traps, this initial RL sensitivity (i.e., the luminescence output per dose
rate unit) will be reset every time the crystal is bleached (and the OSL traps
are emptied). Since the crystal is reset between each measurement, the RL
sensitivity at the start of the exposure is the same from one measurement to
the next. Experimental data suggest that at the beginning of an irradiation,
the instantaneous RL signal is directly proportional to the dose rate. An
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Figure 3.8: Linearity of the OSL response depending on the integration time. The OSL
signal is integrated for durations ranging from 0s (using only the “initial”OSL reading) to
700 s. The standard deviation of the residuals from the linear fit divided by the maximum
response is given for each integration time. Integrating for 100 s or more results in the
most linear OSL response versus absorbed dose.
example for an irradiation in a 6 MV beam for a total absorbed dose of 1 Gy
with dose rates varying from 2 to 6 Gy/min, is given in figure 3.9. These data
also suggest that the sum of the RL signal depends only on the total absorbed
dose, and not on the dose rate. Finally, the slope of the RL signal appears to
be proportional to the square of the dose rate. For doses up to 1-3 Gy, the
RL sensitivity changes are well described by a second order polynomial. For
larger doses, a higher order polynomial is needed, and eventually a saturating
exponential.
3.6.1 Dose assessment from the RL signal
A simple model can be developed to predict the behavior of the radiolumi-
nescence from one crystal. In the following model, we will assume that the
RL sensitivity depends only on the absorbed dose D to the crystal. If the
sensitivity β (in counts/Gy) is expressed as the count rate of the signal per
dose rate unit then this assumption can be expressed as β=β(D). If β=β(D)
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Figure 3.9: Sensitivity changes of the RL signal in a 6 MV beam (absorbed dose = 1 Gy):
the initial RL signal increases linearly with the dose rate (a) and the rate of sensitivity
changes (“slope”) increases with the square of the dose rate (b).
and the dose rate is constant (D˙ = α), then the luminescence output L (in
counts) is the integral of the RL-signal from t = 0 to t = T .
L =
∫ T
0
β(D) · D˙ · dt (3.2)
Since the dose rate is constant, equation 3.2 resolves into:
L = α ·
∫ T
0
β(D) · dt (3.3)
Experimental data suggest that the sensitivity β is a polynomial function of
the dose D: β(D) = a + bD + cD2 + .... It can then be shown that L is
only a function of the absorbed dose D, L = L(D). Since the total lumi-
nescence output does not vary with dose rate, the RL signal can be reliably
use for dosimetry, and assessment of the total absorbed dose. Likewise, if
the dose rate increases linearly with exposure time (D˙=αt), it can be shown
that L = L(D). The implication, in two situations described above, is that
when the same absorbed dose D is delivered with two different dose rates
D˙1 and D˙2, the total luminescence outputs from the crystal will be equal:
L1(D) = L2(D). An experimental verification is shown in figure 3.10. It is
however not possible to draw the same conclusion for any dose rate variation.
Also, it does not necessarily result from the above that there is a proportion-
ality between the total luminescence output and the absorbed dose, as in
L(D)/2 = L(D/2). Hence, the total sum of the RL signal can only be used
in situations where the same absorbed D is delivered in different fashions.
Based on this model, the absorbed dose can be assessed from the RL
signal in two ways. Firstly, the total sum of the RL counts can be considered.
However, this method requires that the assumption β=β(D) holds, and may
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Figure 3.10: RL curves from exposure of the same Al2O3:C crystal to two sources: (a)
6 MV linac (dose rate =12 mGy/s), (b) Cobalt-60 source (dose rate = 2 mGy/s). The
absorbed dose was 1 Gy in both cases. The difference in total RL counts is smaller than
0.2%.
result in some uncertainty on the dose estimate. Secondly, it is possible
to consider only the first readings from the RL signal (which are directly
proportional to the dose rate) and multiply this value by the duration of the
exposure. This method will work well if there is no variation in dose rate
at the beginning of the exposure. It has been observed that certain linacs
take several seconds before the dose rate is stabilized (see figure 3.11). In
this case, the “RL initial” method will lead to high uncertainties on the dose
estimates. For a more reliable dose estimate, both methods are used and
their results are compared.
3.6.2 Correcting for sensitization effects
Using the RL signal in its raw form (i.e., without correcting for sensitiza-
tion or stem effects) does not enable a reliable assessment of the dose rate
variations during the exposure. For this purpose, a correction algorithm was
developed during the course of this project. This method consists in obtain-
ing a reference curve of the sensitization effect.
The correction algorithm used is based on the following approach: if the
sensitivity β is defined as the count rate of the signal per dose rate unit, then
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Figure 3.11: RL at the start up of a Varian clinac 2100: the instability of the dose rate
delivered by the linac at the beginning of the exposure is clearly demonstrated and prevents
the use of the “RL initial” method.
we have
β · ∆D
∆t
=
∆c
∆t
(3.4)
where ∆t is the time resolution of the data acquisition (e.g., 0.1 s), ∆c is
the number counts and ∆D the dose increment during a period ∆t. The
calibration curve of the sensitization of a particular crystal, β(D) is acquired
by exposing the crystal to a relatively high dose of radiation (high enough to
cover the range of doses that will need to be estimated). It is assumed that
β depends only on the absorbed dose. With the crystal bleached to D = 0
before the experiments, the algorithm performs the following steps during
the irradiation:
1. Estimate β at the present D from the calibration curve
2. Acquire reading ∆c/∆t
3. Estimate dose increment according to ∆D = ∆c/β
4. Update dose D ← D + ∆D
5. Repeat from step 1
An illustration of the sensitization correction algorithm is shown in figure
3.12. Figure 3.13 shows the use of the corrected RL signal to resolve a depth
dose distribution in water. Such an experiment is a valid test of the sensi-
tization algorithm since the dose rate varies with the depth of the detector
Risø-PhD-12(EN)
46 Instrumentation and methods
Figure 3.12: An example of the RL sensitization correction algorithm for dose of 2 Gy,
delivered at 3 Gy/min with 6 MV photons. (a) shows the raw RL signal during the
irradiation and the fitted calibration curve. (b) and (c) show the estimated dose rate
(from the corrected RL signal) and the accumulated dose, respectively.
in the water phantom, and 15 data points (resulting in accumulated dose of
2-3 Gy) were acquired without resetting the crystal with laser light between
measurements. The experiment was repeated three times. As can be seen,
the RL data agree with reference data within 0.5% except at shallow depths,
where positioning uncertainties are considerable. This example validates the
sensitization correction algorithm and the reliability of the RL signal for dose
rate and absorbed dose assessment.
3.6.3 Getting rid of the stem-effect: time gating
It is not possible to filter the stem effect out optically since its emission band
overlaps with the RL signal (Marckmann et al., 2005). Temporal methods,
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Depth (mm)
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mm 
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% 
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% 
  Mean Std. dev N 
0 41.1 42.9 1.9 3 
5 85.1 83.7 2.2 3 
10 98.2 97.7 0.3 5 
15 100.0 100.0 0.1 3 
20 98.7 98.7 0.5 3 
25 96.8 96.5 0.2 3 
30 94.6 94.7 0.4 6 
50 86.3 86.4 0.3 6 
100 66.9 66.8 0.1 6 
150 50.9 50.9 0.2 6 
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Figure 3.13: Test of the sensitization correction algorithm. A depth dose distribution was
acquired using only the RL signal, without resetting the crystal with laser light between
measurements. RL data agree closely with reference data (obtained with diodes) and
demonstrate the validity of the correction algorithm.
involving other detectors, have been reported by Jordan (1996) and Justus
et al. (2004) and take advantage of the different lifetimes of the signals.
Radioluminescence in Al2O3:C primarily originates from direct recombination
through the F-centers (see chapter 2), and this process involves a relaxation
time of 35 ms. As a result, the main part of the RL signal is delayed relative
to the irradiation. In contrast, fluorescence or Cerenkov light generated in
the optical fiber has a lifetime of the order of a few picoseconds: this signal
will only be present during the irradiation. Linear accelerators are pulsed
radiation sources (usually delivering a 4 µs pulse every 2.6 ms). Thus, it is
possible to separate the RL signal from the stem effect signal by measuring
the RL in between the beam pulses.
A simple electronic circuit was developed to implement this temporal
gating, using the synchronization signal from the linear accelerator (which
typically triggers single 12-35 µs pulses). These pulses are used to block
counting during and immediately after every beam pulse. The blocking can
be made by gating the input to the counter. This system is illustrated in
figure 3.14 (for more detail, see (Andersen et al., 2005)). Experiments testing
the validity of this temporal gating method are presented in chapter 5.
3.7 Summary
 The RL/OSL dosimetry system can control two optical fiber probes
from the same laptop interface.
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Figure 3.14: Temporal gating for acquisition of the RL signal.
 During the course of the project, considerable improvement has been
made regarding the design of the probes, leading to a better coupling
between the crystal and the optical fiber.
 Absorbed dose assessment from the OSL signal is made by integrating
the OSL decay curve for 100s (which was found to be the optimal
integration time for the fibers used in this project).
 The RL signal is subject to changes in sensitivity and to noise in the
form of light generated in the optical fiber during irradiation (stem
effect).
 Absorbed dose assessment from the uncorrected RL signal can be per-
formed by using the integrated RL signal or the first readings of the
RL signal only.
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 Corrections algorithms developed during the course of the project en-
able to correct the RL signal for sensitivity changes and stem effects.
Risø-PhD-12(EN)

4 Basic dosimetry parameters
for radiotherapy
The basic characteristics and dependencies on beam parameters of the RL/OSL
dosimetry system were first tested in radiation sources at Risø National Lab-
oratory. In this configuration, it is possible to fully automate the experiment:
for example, both the RL/OSL dosimetry system and a small beta source can
be controlled from the Labview interface. Hence, it is possible to launch two
days of measurements without operator intervention. Since at present, every
measurement takes between 15 and 20 minutes (because of the bleaching
procedure), this is a valuable gain of time. However, these measurements are
performed in air and in irradiation conditions very different from a clinical
treatment. Therefore, measurements were repeated in a hospital environ-
ment, where radiotherapy beams and phantoms were available. However,
due to the limited access to clinical beams, fewer data points are available.
For this reason, whenever relevant, laboratory and hospital measurements
are presented together in this chapter. In light of these experiments, the
sources of variability (from the RL/OSL reader, from the crystal, or from
the experimental set-up) are discussed.
4.1 Additional equipment and set-up
Laboratory experiments were performed at Risø and involved three types of
radiation sources:
1. a 1.486 Bq (40 mCi) beta source in a lead casing (90Sr/90Y, average
energy of emitted electrons: 0.196 MeV)
2. a mini x-ray generator from Varian (50 keV, 1 mA) (Andersen et al.,
2003b)
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3. a calibrated gamma irradiation facility, including Cobalt-60 and Cesium-
137 sources with activities of 10 mCi and 8 mCi respectively.
These sources offer flexibility in the range of dose and dose rates for testing
the performance of the RL/OSL dosimeter. However, parameters like field
size, or distance from the source are not always adjustable. Since these
sources have a constant output, the dose delivered to the detector can be
expressed in seconds of irradiation.
Clinical measurements were performed at Malmo¨ University Hospital
(UMAS) and Copenhagen University Hospital (Rigshospitalet). The clini-
cal beams included photon beams with energies ranging from 6 to 18 MV,
and electrons beams from 6 to 22 MeV. The linear accelerators were either
from Varian (type Varian Clinac 2300 or 2100, Varian Medical Systems, Palo
Alto, USA), or Elekta (type Elekta SLi plus, Elekta AB, Stockholm, Sweden).
The measurements were performed either in water, or, when convenient, in
an epoxy resin-based mixture called “solid water” (available from Gammex-
RMI, Inc. Middelton, USA). Solid water has the same density (1.00 g/cm3)
and electronic density (3.34 x1023 electrons per gram) as water and is widely
used in radiation therapy dosimetry. Figure 4.1 illustrates a simple set-up of
the dosimeter in a solid water phantom, as well as the different parameters
used to commonly characterize a specific beam configuration in radiotherapy.
The output of the linear accelerator is expressed in monitor units or “MU”.
This parameter basically reflects the irradiation time but also takes into ac-
count the small variations in output that can occur due to power fluctuations.
Linear accelerators are usually calibrated to give 1Gy/100MU at a specific
location (e.g, at 100 cm SSD and 1.5 cm depth for a 6 MV beam using a 10
cm x 10 cm field).
All the data in this chapter (unless otherwise specified) have been ac-
quired early in this project, where only fiber 01 was available, and no sensiti-
zation correction or time-gating algorithm was developed. Nonetheless, these
measurements offer insight on the characteristics of the “raw” RL and OSL
signals, and provide a good base for understanding the challenges of accurate
dose assessment from these signals. According to the data analysis protocol
described in chapter 3, the analysis of the RL signal will be made using only
the first readings (to avoid overestimates due to the sensitization effect). The
OSL signals were integrated for 100 s to provide the most reliable absorbed
dose estimate.
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Linac head
solid water
dosimeter
SSD
FS
d
Figure 4.1: Set up for radiotherapy experiments. Parameters illustrated are the source-
to-surface distance (SSD), field size (FS), and depth (d).
4.2 Reproducibility
The stability in response of the RL/OSL dosimetry system was first tested
using the mini x-ray source at Risø. A fixed absorbed dose (500 s irradiation
at 50 kV and 0.3 mA, ∼0.5 Gy) was delivered 66 times to fiber 01, and the
crystal was bleached for 20 minutes after each irradiation. The results are
presented in figure 4.2. For the OSL signal, all data points are well within ±
0.5%, with a standard deviation of 0.1%. These results include variations due
to the output of the x-ray tube and show that the system has an excellent
short-term reproducibility. They also demonstrate that the crystal can be
regenerated as part of the measurement procedure.
The standard deviation for the RL response is 0.6% over 66 measurement
points but RL results for this crystal present a upward trend. The cause
of this trend is not well understood, but hypotheses include temperature
variations in the laboratory facilities and a deep-trap effect, which would
affect mostly the RL signal. The impact of this trend is limited if frequent
calibrations are made, as is the case in all the experiments presented in this
work.
The reproducibility was also tested in clinical photon beams of 6 MV and
18 MV in a water tank positioned at 100 cm SSD. The beam settings were:
10x10 cm2 field, 1 Gy delivered at 3 Gy/min, with the detector positioned at
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Figure 4.2: Reproducibility of the RL/OSL system in laboratory conditions: OSL (a) and
RL (b) responses for 66 consecutive measurements.
depth dose maximum. Beams from this linear accelerator were reported to
be stable (within 0.3% for the 6 MV beam and 0.7% for the 18 MV beam)
for the month preceding this experiment. Measurements were repeated 10
times in the 6 MV beam and 8 times in the 18 MV beam. The initial “peak”
of the OSL signal is reproducible with a standard deviation of 0.9% in the
18 MV beam (1.5% at 6 MV). The integrated OSL signal, however, has a
reproducibility of 0.4% (0.7% for 6 MV, 1SD). This indicates the possibility
of small fluctuations in the laser output. Figure 4.3 shows the RL signal,
the first 5 seconds of the OSL signal, and the background signal after 400
seconds of bleaching for the 10 experiments. The initial readings of the RL
signal (before any sensitization occurs) show a standard deviation of 0.8% (in
both beams). The sum of the RL signals is here reproducible with a standard
deviation of 0.5% (in both beams). It should be noted that the variation of
the RL results in this experiment is random, which confirms a good short
reproducibility of the RL signal.
4.3 Linearity and dose rate response
The linearity of the dose response of the RL/OSL dosimeter was investigated
using the 90Sr source at Risø. This source has a low dose rate and can deliver
accurate doses of the order of 1 mGy. Results are presented in figure 4.4 and
show that the dose response of the OSL signal is linear from a few mGy to
3Gy (R2 >0.999).
The measurement of absorbed dose from a detector intended for use in
clinical dosimetry has to be independent of variations in the dose rate. Dose
rate measurements were performed using the 60Co and 137Cs gamma sources
at Risø, because of the possibility to increase the source-to-detector distance
(in air) and thereby obtain very low dose rates. The results are illustrated
in figure 4.5. It is clear from figure 4.5 that the instantaneous RL signal
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Figure 4.4: OSL signal versus absorbed dose: results are presented in log scale (a) and
linear scale (b).
(as estimated from the first readings) increases linearly with dose rate if no
sensitization effect is present. However, the integrated RL signal (without
sensitization effect) should be proportional only to the total absorbed dose
and independent of dose rate.
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Figure 4.5: OSL signal versus dose rate in 60Co and 137Cs gamma sources
The response of the RL/OSL dosimeter was investigated in a water tank
irradiated with a 6 MV photon beam (10x10 cm2, 100 cm SSD). The RL/OSL
detector was positioned at 5 cm depth in the water, and 100 MU (“monitor
units”, corresponding to 0.85 Gy at the point of measurement) were repeat-
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edly delivered using different values of the pulse rate of the linear accelerator
(0.85-5.1 Gy/min, or 100-600 MU/min). It should be noted that in this ex-
periment, the instantaneous dose rate is not actually varied, but rather the
number of dose pulses delivered by the accelerator in a certain amount of
time. However, the response of the dosimeter to pulse rate is of clinical inter-
est, and the term “dose rate” is often used instead of “pulse rate”. In figure
4.6, the OSL signal normalized to the average of all measurements is plotted
versus the pulse rate, and the variation is 0.3% (1 SD) for the range of pulse
rates included in this investigation. Figure 4.6 also shows the excellent lin-
ear relationship between the amplitude of the initial RL signal and the dose
(pulse) rate (R2=0.9999).
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Figure 4.6: Dose rate response of the RL/OSL system in a 6 MV beam: (a) normalized
OSL results; (b) Initial RL signal versus dose rate (here, pulse rate).
4.4 Energy dependence
As mentioned in chapter 2, Al2O3:C has an atomic number higher than water
(10 vs 7). Therefore, the RL/OSL detector will show some energy depen-
dence, i.e. the output signal from the detector might vary with the radia-
tion quality used. In all the following measurements, the absorbed dose was
determined using an ionization chamber calibrated in terms of absorbed-
dose-to-water at the Swedish secondary standard dosimetry laboratory. The
readings were normalized to the average of the RL or OSL signals for all
measurements. Figure 4.7 shows the variation of the signal found when an
absorbed dose of 2 Gy is delivered to the position of the detector at a depth
of 10 cm in water, using 6 MV and 18 MV photons from an Elekta linac.
The variation in output from the detector was 0.6% (1 SD) for both RL and
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Figure 4.7: Energy dependence of the RL/OSL dosimeter in 6 MV (circles) and 18 MV
(triangles) photon beams. (a) OSL results, (b) RL results.
OSL signals. This is acceptable for clinical purposes, although for greater
accuracy, some correction factors could be determined. Additionally, some
measurements were performed in water comparing gamma rays from a Cobalt
source (with an energy of approximately 1.25 MeV) and 6 MV photons. The
results from the OSL readings, normalized to ion chamber measurements,
show a deviation of 2.3% between the average response to Cobalt and to 6
MV (see figure 4.8).
Theoretical calculations from Monte Carlo simulations were performed
by L Buckley and DWO Rogers at Carleton University (Ottawa, Canada).
These simulations were based on the code EGSnrc (Kawrakov and Rogers,
2000), including a new correlated sampling algorithm (Buckley et al., 2004a)
and were based on the large Al2O3:C probe from Risø (fiber 01). The results
show that an energy dependence of about 3% is expected between 60Co and
18 MV (Buckley et al., 2004b), but that this variation in response should be
less than 1% between 6 and 18 MV beams. This estimate is in agreement
with experimental RL/OSL results. As mentioned in chapter 2, the energy
dependence of the probes should decrease for smaller crystals.
4.5 Angular dependence
A dosimetry system is usually calibrated in a set-up such as described in
figure 4.1 where the gantry is not rotated (“0 degree angle” set-up). However,
in vivo measurements are often performed with a rotated gantry. Hence the
variation in response of the RL/OSL system with respect to the angle of
incidence of the beam is an important parameter. The angular dependence
was investigated only in hospital conditions. The detector was positioned
in the center of a spherical and hollow glass phantom, filled with water.
The diameter of the sphere was 3 cm, enough to provide build-up for a
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Figure 4.8: Energy dependence between 60Co (circles) and 6 MV (triangles). OSL results
are presented and are normalized by ionization chamber readings. The solid and dotted
lines represent the average values of OSL response for 60Co and 6 MV, respectively.
6 MV photon beam. The Al2O3:C detector was positioned at the beam
isocenter. At a gantry angle of 0 degree, the optical fiber was placed along
the central axis of the beam in the position illustrated in figure 4.9. In order
to minimize the effects of a potential set-up error, data from 0 to 179 degrees
are normalized to the value at 90 degrees, while data from 180 to 360 degrees
are normalized to the value at 270 degrees. The OSL and the RL signals
were found to have standard deviations of 1.3% and 1.7% respectively.
4.6 Crystal temperature
The temperature dependence of the system was only tested in laboratory con-
ditions. The response of the dosimetry system should not vary with crystal
temperature, as measurements can be performed at room temperature (18-
22) or at body temperature (35-40 ). The RL/OSL dosimeter was tested
at a variety of ambient temperatures ranging from 0 to 45. This experi-
ment was performed with fiber 40B. The results are included in figure 4.10.
The standard deviation of the results over the range of temperature studied
is 1.3% for long integration times (≥100s). However, it should be noted that
the temperature dependence of the OSL signal increases if short integration
times are used because of the slow depletion of shallow traps at low temper-
atures. This effect is illustrated in figure 4.11. Hence, an integration time
over 100 s is recommended to minimize the temperature dependence of the
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Figure 4.9: RL/OSL responses versus the angle of incidence of the beam. Black circles:
OSL, Grey crosses: RL. The fiber was positioned along a vertical, downward axis
OSL response. The RL signal does not seem to be affected by temperature
to the same degree (see 4.12). However, the afterglow following the end of
the irradiation (see 2.3) exhibit a higher decay rate with increasing temper-
atures. Indeed, the decay rate of shallow traps is determined by the ambient
temperature, and will thus increase with high temperatures.
4.7 Depth dose distributions
It is important from a clinical point-of-view to evaluate the ability of a new
dosimeter to resolve depth-dose distributions, as it illustrates the behav-
ior of the detector at depth, where it is exposed to slightly different beam
spectra. In the following investigation, RL/OSL data have been compared
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Figure 4.10: OSL response of the probe at different temperatures: the variation in response
can be minimized if a long integration time is used.
to the results obtained with a commercial p-doped Si-diode detector (Scan-
ditronix/Wellho¨fer, Uppsala, Sweden). Figure 4.13 shows depth-dose distrib-
utions in water obtained at UMAS with 6 MV and 18 MV beams respectively,
using a 10x10 cm2 field set at 300 MU/min, corresponding to 3 Gy/min at
the depth-dose maximum. All data have been normalized to the depth-dose
maximum. On figure 4.13, it can be observed that the largest discrepancy
between diode and RL/OSL data occurs at shallow depths. This can be ex-
plained partly by the positioning uncertainty in a high-dose gradient as well
as by the under-response of diodes at shallow depth (Heydarian et al., 1996).
Beyond the build-up region, the agreement between diode and RL/OSL data
is 1% (1SD). Depth dose distributions from electrons beams (6,12 and 22
MeV) are presented in figure 4.7. The agreement between RL/OSL and
diode data is within 1.1% for 6 MeV and 0.9% for 22 MeV (1SD). Absolute
deviations between the diode data and the RL/OSL data are larger for 6
MeV, possibly because of the sharper dose gradients. Discrepancies between
RL and OSL results can also be observed and are probably due to the the way
the RL analysis is performed (using the sum of the uncorrected RL signal,
see chapter 3).
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Figure 4.11: OSL response of the probe at different temperatures. The height of the initial
signal varies with temperature, but the effect fades after a couple of seconds, suggesting a
faster depletion of shallow traps at higher temperatures.
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Figure 4.12: RL response of the probe at different temperatures. (a) total RL signal: no
clear trend can be observed with increase in temperature; (b) detail of the afterglow: the
decay rate increases with high temperatures.
4.8 Spatial resolution
A lateral profile was measured in a 5x5 cm2 field for 6 MV photons (with
an Elekta SLi plus at UMAS), at a depth of 10 cm in a water phantom,
illustrated in figure 4.8. The diode and RL/OSL data were normalized to the
result obtained at the center of the field. These results show that the spatial
resolution of the RL/OSL detector system makes it suitable for measurements
of depth and lateral dose distributions in clinical photon beams. The spatial
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Figure 4.13: Depth dose distributions for 6 and 18 MV photons. Solid line: diodes, hollow
symbols: OSL, full symbols: RL.
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Figure 4.14: Depth dose distributions for 6 and 22 MeV electrons. Solid line: diodes, open
symbols: OSL, filled symbols: RL. The inserts on top of the graphs show the discrepancy
between diode and luminescence data.
resolution of the RL/OSL dosimeter could also be improved by using smaller
crystals, such as those from fibers 48 and 49.
4.9 Sources of variability
In light of these measurements, several source of variation in the response of
the RL/OSL dosimetry system have been identified and are listed in table
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Figure 4.15: Lateral profile for 6 MV photons. Solid line: diodes, hollow symbols: OSL,
full symbols: RL.
4.1. Some parameters which have not been mentioned previously are also
detailed in this section.
4.9.1 Mechanical sources
Optical transmission effects
In fiber 01, no adhesive was used between the crystal and the fiber, which
were held together by a shrinkflex wrapping. As a result, slight motion of
the crystal with respect to the end of the optical fiber were possible. This
coupling was improved with the new probe design using NOA-61. Some
variability is also present when fibers are detached from the reader and then
reattached to it: SMA connectors do not offer a highly reproducible coupling,
and this effect has been shown to effect the response of the RL/OSL dosimetry
system by up to 20%. Consequently, the system was calibrated every time
the fibers were re-attached to the optical reader. In some situations, the
fibers are taped to the treatment table: for example, they need to be out of
the way of the nursing personnel during patient set-up. In contrast, during
a phantom experiment, the fibers are left to run freely on the floor. Taping
the fibers to the table may necessitate to bend them slightly, but should not
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interfere with signal transmission as long as the fiber is undamaged. If the
fiber cable is, on the contrary, damaged, the transmission of the luminescence
will be impaired.
PMT temperature or “warm up effect”
The time interval between the system ”power-on” and the data acquisition is
an important factor. Indeed the temperature inside the reader varies after
start-up and takes some time to stabilize. We know from experience that
measurement taken shortly after the system has been switched on exhibit
poor reproducibility (up to 10% standard deviation). Further investigation
revealed that this “warm up effect” resulted in a decrease of the signal of
0.6% per Celsius degree. The logical recommendation is that the reader
should stay switched on as long as possible before a measurement.
4.9.2 Effects due to the crystal
Luminescence
As was demonstrated in this chapter, the temperature of the crystal is going
to affect is luminescence output. Another source of variability is the presence
of residual signal due to improper bleaching: if the crystal is not stimulated
with laser light for a sufficient amount of time, a residual signal will be present
in the next measurement. This effect may amplify with each measurement
until the accumulated residual signal can have a noticeable effect on the
dose estimate. In the dose rate dependence experiment presented in section
4.3, the OSL signal presents a “trend”: the absorbed dose estimate seems to
decrease with repeated measurements. This phenomenon can be observed
if the fibers are not properly bleached after each measurement. Hence, care
must be taken to bleach the crystal as long as possible (and for at least
400s with the laser power presently used in the RL/OSL system) between
measurements. This is especially valid if the crystal has been exposed to
a high dose (>5 Gy). The stem effect, whose importance is related to the
signal-to-noise ratio of the “crystal+fiber” assembly is also a considerable
source of variability of the RL signal.
Dosimetry
Other factors affect the response of the crystal, although they are not related
to luminescence phenomena. For example, the angular dependence is linked
to the shape of the detector. The energy dependence is caused by the higher
Zeff of Al2O3:C . External factors, such as the stability of the radiation source
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solid water
probes
Figure 4.16: Position of fibers in a solid water phantom in presence of air cavities.
(here, the linac) as well as the precision of the set-up will introduce some
variability in the measurements.
One last parameter is related to the composition of the solid water phan-
tom used for some measurements in this chapter. For measurements in a
solid water phantom, a groove was drilled into a solid water plate in order to
accommodate the fibers. However, the fibers do not totally fill this groove.
Hence, the phantom is actually a inhomogeneous volume consisting of air and
solid water (as well as plastic fibers). The dose distribution may differ slightly
from the one which would be performed on a homogeneous phantom (Har-
aldsson et al., 2003). This effect may be more significant at certain angles,
which means it is more critical in IMRT than in conventional measurements.
Its impact is difficult to quantify exactly, but should add an uncertainty of
at least 1-2% on the absorbed dose estimate.
4.10 Conclusion
It can be concluded from this investigation that the RL/OSL dosimeter does
not suffer from any major dependence (>5%) on beam parameters. The
variation in response of the RL/OSL detector was generally smaller than
1.5% (1SD) and in many cases smaller than 1%. One exception is the angular
dependence, though this effect may be reduced with smaller crystals. These
results suggest that the overall accuracy of RL/OSL dosimeter is satisfactory
for radiotherapy purposes.
The potential sources of variability (mechanical, crystal-related, dosimet-
ric) have been identified and, when possible, quantified. Bearing these un-
certainties in mind is useful in order to use the RL/OSL dosimetry in the
most reliable way when it is applied to treatment-like measurements.
Risø-PhD-12(EN)

5 Clinical applications in
radiotherapy
Once the basic dosimetric parameters had been tested and judged satisfac-
tory, the RL/OSL dosimetry system was submitted to more realistic situa-
tions: a conventional radiotherapy treatment in an anthropomorphic phan-
tom and IMRT treatment simulations on a solid water phantom. Three
in vivo measurements were performed on IMRT patients. These treatment
modalities present an increasing level of complexity from a dosimetric (and,
for the patient measurements, practical) point of view. The results from
these measurements are the main topic of this chapter, and a careful review
of the challenges inherent to each situation is given.
5.1 Conventional radiotherapy simulation in
an anthropomorphic phantom
The first experiments in a patient-like set-up were performed at Malmo¨ Uni-
versity Hospital in Sweden in April 2003 (Aznar et al., 2004). Data were
acquired at a sampling rate of 10 Hz, using fiber 01. We chose to test the
RL/OSL dosimetry system by simulating a relatively simple treatment of
the pelvic area. An anthropomorphic phantom (Alderson Rando Phantom,
Alderson Research Labs, Inc., Stamford, USA) was chosen, and the pelvic
portion of this phantom was scanned in a CT-scanner (see figure 5.1(a)).
Two treatment plans were then designed with the TMS treatment planning
system (Helax, Uppsala, Sweden).
Two types of dose delivery were chosen (see figure 5.2):
 The first plan consisted of two parallel-opposed“anterior-posterior”and
“posterior-anterior”(AP-PA) open fields, delivered using 10 MV photon
beams with field size 10x10 cm2.
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(a) Position of the fiber in the phantom (b) CT scanning
Figure 5.1: Position of the fiber in the anthropomorphic phantom during CT-scanning.
2-field plan 3-field plan
AP
PA
Lateral
wedge
Figure 5.2: Treatments plans for the anthropomorphic phantom: the first plan consists of
two opposed fields in the anterior-posterior direction; the second plan includes, in addition,
a lateral field and wedges for dose homogeneity within the target volume.
 The second plan included, in addition to the AP-PA fields, a 7x10 cm2
right lateral field, as well as some filters (“wedges”) for the AP-PA fields
to obtain a homogeneous dose distribution
Both plans were normalized to deliver 1.0 Gy at a specific point in the phan-
tom.
This normalization point was chosen to be in one of the channels of the
phantom, where the fiber could be introduced. An absorbed dose of 1 Gy was
planned to be delivered at the location of the crystal with an Elekta SLi plus
accelerator. The RL signal was collected for each field during irradiation,
and the OSL signal was measured at the end of each treatment fraction.
Each plan was delivered at two occasions. These results were compared to
a calibration dose of 1.0 Gy at 100 cm SSD in solid water, at the depth of
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2 cm, which was repeated three times before the delivery of the treatment
plans, and once after.
Hence, in all these experiments, the same absorbed dose of 1 Gy was
delivered to the RL/OSL detector in three different fashions:
1. in a simple set-up with a solid water phantom
2. in an anthropomorphic phantom with a 2-field plan and only 6 MV
photons
3. in an anthropomorphic phantom with a 3-field, and using 6 and 10 MV
photons.
Table 5.1: Results from the experiment using an anthropomorphic phantom.
Type of irradiation OSL (Gy) RL (Gy)
Calibration 1 1.008 1.003
Calibration 2 1.001 1.004
Calibration 3 1.001 1.004
2-field plan 1 0.977 0.976
2-field plan 2 0.992 1.003
3-field plan 1 0.995 1.000
3-field plan 2 0.978 0.986
Calibration 4 0.990 0.989
Since several fields are considered, each yielding a slightly different dose
rate at the location of the detector, the sum of the RL signal was used to
establish a dose estimate. Table 5.1 gives a detailed view of the results. It
can be seen that there is a tight agreement between the RL and OSL results
in every case, which suggests that the stem-effect and the sensitization phe-
nomena do not impair a reliable dose estimate in this relatively simple set-up.
Results from both the 2-field and the 3-field treatments are approximately
2% below prediction. This discrepancy is likely to be caused either by a
small imprecision in setting up the anthropomorphic phantom or positioning
the fiber inside the channel, or by uncertainties in the dose prediction from
the TPS (most TPS in clinical use today claim an accuracy of 2-3%). The
results of the four calibrations agree within 1% where the largest deviation
was found for the set-up after delivery of the four treatment plans, includ-
ing the uncertainty caused by re-positioning the detector in the field at the
specified depth of measurement. An analysis of variance (ANOVA) between
calibration data and treatment data shows that no significant variation can
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be observed between those two groups (p=0.5 for OSL data, and p=0.27 for
RL data). This suggests that the RL/OSL system can reliably estimate the
dose from 2-field and 3-field treatments in a solid water phantom: the orien-
tation of the beams, the difference in energy spectrum (due to the position
at depth, the presence of wedges and the inhomogeneities in the anthropo-
morphic phantom) as well as the different beam energies, did not affect the
response of the RL/OSL dosimeter.
5.2 IMRT simulation in a solid water phan-
tom
To test the ability of the RL/OSL dosimetry system to assess the absorbed
dose to the target volume in these extreme dosimetric conditions, several
phantom experiments were first performed in a solid water phantom. The
set-up was similar to the one used for the treatment QA with the ionization
chamber. The following data was acquired with fibers 48 and 49. The solid
water phantom was set up on the couch. Slabs were selected so that the
total thickness of the phantom was 15 cm, and the fibers were positioned
2 cm below the surface. A quick reproducibility and linearity check was
performed and used as calibration data. Particularly, several shots of 200
MU were delivered with a 6 MV beam to deliver an absorbed dose of 1.96 Gy
at the position of the fibers. The IMRT plan was then loaded and delivered
to the phantom. RL data were acquired during the duration of the exposure
(around 15 minutes) and the resulting signal is displayed in figure 5.3. OSL
was acquired once the delivery was completed, and the process was repeated
3 times. The results are presented in table 5.2.
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Figure 5.3: RL signal for the IMRT treatment in a solid water phantom: (a) linear scale,
(b) semi-log scale.
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Table 5.2: RL/OSL results from the IMRT treatment in a solid water phantom with fibers
48 and 49.
Signal Fiber 48 Fiber 49 TPS Fiber 48 Fiber 49
Dose (Gy) Dose (Gy) Dose (Gy) vs TPS vs TPS
RL1 2.202 2.221 20.7% 19.7%
RL2 2.225 2.249 22.2% 20.9%
RL3 2.225 2.245 22.0% 20.9%
OSL1 1.819 1.812 1.84 -1.1% -1.5%
OSL2 1.812 1.807 -1.5% -1.8%
OSL3 1.807 1.796 -1.8% -2.4%
5.2.1 RL results: stem effect and sensitivity changes
The RL data show a clear overestimate, which is mainly due to the influence
of the stem effect and of the sensitivity changes throughout the dose delivery.
In most experiments described in chapter 4 and in the anthropomorphic
phantom experiment, the crystal is in the center of the irradiation field. In
dynamic IMRT however, because the field shape changes during the exposure,
the crystal might be out of the field at some occasions, while some portion
of the optical fiber is being irradiated. In this situation, only the stem effect
will be recorded. The total signal to noise ratio of the RL signal is then
greatly affected. Moreover, with complex treatments such as IMRT, the dose
rate varies greatly during a very short time, as is clearly seen in figure 5.3.
Hence, the sensitization effect can not be contoured by using only the initial
RL readings (as was done in chapter 4). As a result, though each field can
clearly be visualized, the uncorrected RL signal can not be used to estimate
the absorbed dose to the detector.
5.2.2 OSL results
The agreement between the OSL data and the TPS prediction is within 3%.
Apart from the possibility of inaccuracies from the TPS itself, the potential
sources of discrepancy are analyzed in the following sections.
Positioning uncertainties
The raw RL signal can be used as a “fingerprint” of the position of the
two fibers. Indeed, if the fibers were apart for more than, say, 1mm, their
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Figure 5.4: The RL signal can be used as a “fingerprint” of the fibers’ respective positions.
Here, the signals from fiber 48 and fiber 49 overlap, i.e. the two fibers were in the same
measurement location.
respective crystals would not always be in the beam simultaneously: this
should be noticeable looking at the shape at the RL signals. Figure 5.4
shows that the RL signals from both fibers are indistinguishable: we can
safely conclude that the two probes were at the same measurement location.
However, there are other types of positioning uncertainties. IMRT is by
definition a highly conformal treatment modality, and as a result, there is a
sharp dose fall-off outside the target volume. If the probes are located in one
of the high gradient dose regions, a positioning uncertainty of 1 mm could
result in a difference of several percent on the total absorbed dose estimate.
Even though care was taken to position the probes as precisely as possible at
the isocenter, some issues could have been overlooked. For example, figure
4.16 shows the position of the probes in the solid water phantom, and the
potential uncertainty in positioning in the AP direction. The effect could
add an uncertainty of about 2% on the final absorbed dose estimate.
5.3 In vivo IMRT
5.3.1 IMRT with TLDs at Rigshospitalet
Intensity modulated radiation therapy is a complex procedure (see chapter
1) and in vivo dosimetry is strongly recommended. At Rigshospitalet, 2-
3 patients per month are treated with IMRT for cancers of the head and
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neck region. In vivo dosimetry was usually performed with TLDs (Haralds-
son et al., 2003). Each patient’s treatment plan is tested with an ionization
chamber in a solid water phantom as part as the treatment QA (see chapter
1). The day of the first treatment fraction, several LiF TLD rods (1 mm
ø x 6 mm `) are positioned inside a catheter (Maersk Medical A/S) along
with lead markers, in order to aid the localization of the pellets on the por-
tal images. The catheter is then inserted through the nose of the patient
down into the oesophagus. After the treatment fraction is delivered, the
catheter is withdrawn and the TLDs are extracted and measured in a special
TL apparatus (Harshaw 5500 reader). It has been reported that the TLD
readings from 6 patients (15 fractions, 153 measurements) show an average
ratio of measured versus planned (TPS) dose of 0.99±0.06 (Van Esch et al.,
2002). Though this procedure has the advantage of giving a dose estimate at
several points within the treatment volume, it is time consuming. As an al-
ternative, three conclusive in vivo measurements have been undertaken with
the RL/OSL dosimeter between September 2003 and February 2004. These
measurements were performed in patients treated for cancer of the head and
neck region with IMRT. The catheter/lead markers assembly was the same
as the one used for the TLDs. Measurements were carried out either with
fiber 43 alone or with both fiber 48 and fiber 49 inserted in the catheter.
In the latter case, two separate estimates of the absorbed dose at the same
point are obtained.
5.3.2 Protocol for RL/OSL measurements in patients
With in vivo measurements, some practical issues must be considered, such
as minimizing the interference of the measurement with the actual treatment.
Also, calibration must be kept to a minimum if it has to be performed shortly
before or after the treatment (since the machine has to be used to treat more
patients). We established the following procedure:
 Before treatment: one data point was obtained in solid water (2 Gy)
 During treatment: real-time RL acquisition
 After treatment: the fibers are removed from the catheter, the system
is shut down and moved to another location where OSL is acquired.
 Additional dose-response tests are performed for the calibration of the
RL/OSL system.
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5.3.3 Potential sources of uncertainty
Positioning: probe, set-up and patient motion
In addition to the positioning issues discussed for the phantom case, several
uncertainties are specific to an in vivo measurement. Indeed, if the probe
moved away from the lead marker during the insertion of the catheter in
the patient, it is unlikely to be noticed. The set-up of the patient itself is
subject to uncertainties and this can affect the dose delivery at the position
of the probe. Finally, even if the patient is perfectly set-up and immobilized,
the internal organs can move by 1.5 mm during a single treatment fraction
(due to breathing, deglutition, etc) (Kim et al., 2004). If the detector is
positioned in a high dose gradient, all these small motions can lead to a
considerable discrepancy between the TPS estimates and the absorbed dose
recorded by the crystal. The importance of positioning the detector in a
region of low dose gradient seems obvious. In practice however, this is not
easily achievable, because of time and imaging constraints. If the dose is
positioned in a high gradient region, a 2 mm uncertainty in positioning could
result in a 5% uncertainty on the dose estimate.
TPS error: inhomogeneities
The solid water phantom with which the TPS calculations were performed
for the previous experiments is homogeneous. The head and neck area of a
real patient will contain soft tissue, air (sinuses, trachea) and bone (facial
bones, spinal processes). The algorithms used to model the interaction of
radiation with matter have greatly improved over the years. Nonetheless,
the way they handle interactions in an inhomogeneous media is not perfect.
It has been shown that the uncertainty on the TPS dose estimates can be
significant, especially with the presence in inhomogeneities in the medium
(Knoos et al., 1995), (Jeraj et al., 2002). In the case of a head and neck
patient, this uncertainty could be as high to 1-2%.
5.3.4 Results from RL/OSL in vivo measurements
OSL Results from the 3 patient measurements are presented in table 5.3.
The uncertainty on the OSL dose estimates is given in the form of confi-
dence intervals (95%). OSL dose estimates are within 2% of the predicted
dose for all measurements except one. In the third patient measurement,
fiber 48 give an absorbed dose estimate which lies 19% below the TPS value.
The “fingerprint” from the RL signal shows that the two fibers were at the
same location in the patient. Because of the sensitization and stem effects
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Table 5.3: Results of three in vivo measurements: OSL absorbed dose estimates versus
predicted doses from the treatment planning system. Confidence intervals (95%) are given
for the OSL estimates.
Patient Fiber OSL (Gy) TPS (Gy) OSL vs TPS
2 43 1.73 (1.66-1.80) 1.760 -1.7%
4 48 1.83 (1.79-1.87) 1.852 -1.1%
4 49 1.82 (1.79-1.85) 1.852 -1.7%
5 48 1.64 (1.63-1.65) 2.030 -19%
5 49 2.06 (2.04-2.08) 2.030 1.5%
(which are not corrected for), it is expected that the RL signal will lead to
a gross overestimate of the absorbed dose at the location of the detector.
Indeed, in most cases, analysis of the RL signal leads to an overestimate the
dose by 20% or more. However, in the third patient measurement, the RL
dose estimate from fiber 48 is actually 11% below the TPS prediction. After
the patient measurement, the dose-response test of fiber 48 showed excel-
lent reproducibility and linearity of the signal. This suggests a technical or
mechanical problem during the patient measurement. Indeed, the transmis-
sion properties of fiber 48 were tested and showed that the fiber had been
damaged. As a result, the transmission of laser light or luminescence signal
is much lower when the fiber is bent (see section 4.9.1). This was the case
for the patient measurement: during the treatment, the fiber was bent and
taped to the treatment table to avoid interference with the patient set-up
(resulting in a reduced RL acquisition). Right after the treatment, while the
OSL was acquired, the fiber was rolled on itself to avoid lying on the floor.
However, the dose-response test was performed in a treatment room where
the fiber was straight and transmission was not impaired. Apart from this
particular instance, the RL/OSL dosimetry system showed to provide reliable
and accurate absorbed dose estimates for IMRT treatments. The RL signal,
however, was not used to its full potential in the absence of stem effect and
sensitization corrections.
5.4 IMRT with improved RL analysis
In summer and fall 2004, some IMRT measurements were repeated using the
sensitization correction and temporal gating methods described in chapter 3.
With these methods, it is possible to correct for the sensitization effect by
calibrating the sensitivity changes in the crystal with respect to accumulated
dose. Moreover, temporal gating takes advantage of the longer lifetime of the
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radioluminescence compared to the light generated in the optical fiber. In
IMRT treatments, dose rate variations are large and stem effects are impor-
tant since the detector is not always in the irradiation field. Hence, IMRT
measurements represent the ultimate test of the RL correction methods.
Fibers 43 and 37 were used in a solid water phantom. The system was
first calibrated with a fixed field (10 cm x 10 cm) of a 6 MV beam, with
the detectors positioned slightly apart at a depth of 2 cm in a 15 cm thick
phantom. The position of the two fibers is shown in figure 5.6. In order
to take into account the influence of small uncertainties in the positioning
of the fibers, several dose estimates were obtained from the TPS within a 2
mm cube centered on the assumed location of the fibers1. Three successive
deliveries of the IMRT plan were performed. The reproducibility of the RL
signal is illustrated in figure 5.5. Figure 5.7 illustrates the RL “fingerprint”
phenomenon: the fibers are only a few mm apart but their luminescence
output are considerably different, as is expected in a high dose gradient.
The absorbed dose estimates from RL and OSL are summarized in table
5.4. Because the RL results are now meaningful, field-by-field absorbed dose
estimates are presented. RL dose estimates are highly reproducible among
the 3 measurements at 0.2% (1SD) for fiber 43 and 0.04% for fiber 37. OSL
results showed standard deviations of 0.7% and 0.04% for fibers 43 and 37,
respectively. The results show a good agreement between RL and OSL dose
estimates (1% 1SD for fiber 43, 0.3% 1SD for fiber 37). Luminescence results
deviated from TPS values by 2% (RL) and 3% (OSL) for fiber 43 (probe
A), and by 1% (RL) and 0.4% (OSL) for fiber 37 (probe B). Field-by-field
dose estimates from the RL signal are highly reproducible and always within
the “dose estimate window” given by the TPS, except in the case of field #5
for both fibers. These results suggest that both fibers can reliably estimate
the absorbed dose in IMRT measurements. They also indicate that fiber 37
is more precise, and possibly more accurate than fiber 43. This difference
between the two fibers is probably due to the inherent characteristics of each
crystal (see chapter 3). The results also validate the RL correction methods,
and confirm the potential of the RL signal for field-by-field absorbed dose
estimates.
1Since the TPS calculations are performed with a voxel size of 5 mm, measuring the
dose 2 mm away from the point of measurement will only give qualitative information
about the presence of a dose gradient. However, the “dose estimate window” read in this
2 mm cube might not accurately represent the quantitative dose variation.
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Figure 5.5: Field 1 dose delivery versus time with probe A (fiber 43). Note the high
reproducibility from treatment to treatment (IMRT-G1, G2, and G3).
Figure 5.6: Position of fibers 43 (probe A) and 37 (probe B) in the solid water phantom.
5.5 Conclusion
The measurements presented in this chapter show that the RL/OSL dosime-
ter can estimate the absorbed dose within 2-3% even in complex situations,
such as in vivo IMRT. Some results suggest that this accuracy could be
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Figure 5.7: Field by field dose delivery versus time for probes A and B. The offset between
the signals confirms that the fibers are a few mm apart.
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improved to reach 1% if care is taken to choose a good fiber (i.e., highly re-
producible, and showing no sign of damage) and to follow a certain protocol
(i.e., very accurate set-up, adequate warm-up of the system before the mea-
surement, etc). The RL and OSL signals can both reliably estimate absorbed
doses. The RL signal also offers the possibility of estimating the individual
dose from each field in an IMRT treatment. Hence, the RL/OSL can provide
two independent dose estimates from the same in vivo treatment: one inte-
grated dose estimate (OSL) and one real-time dose estimate (RL), which can
be compared to one another, and act as a useful “diagnostic tool” in case of
an odd result. These measurements also demonstrate the considerable poten-
tial of the RL signal for giving a “fingerprint” of the fibers: small positioning
errors can be picked up by looking at the unique dose rate information deliv-
ered by each fiber. Two patient measurements failed for reasons unrelated to
the performance of the RL/OSL dosimetry system (for one patient treatment,
the lead markers were not visible and the location of the probe was unknown;
for the other, a manipulation error occurred and the PMT was switched off
during OSL acquisition). Three conclusive patient measurements for IMRT
of the head and neck region were performed and confirmed the considerable
potential of the RL/OSL dosimetry system.
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6 Clinical applications in
mammography
In vivo dosimetry in mammography is a different challenge than in radiation
therapy. First of all, it is not a common procedure: most of the dosimetry
checks in mammography are done without any patient present and are per-
formed in air or with a plastic phantom, usually using ionization chambers.
In vivo measurements have been reported with TLDs (Zoetelief et al., 1996;
Berni et al., 2002) and MOSFETs (Peet and Pryor, 1999; Dong et al., 2002)
but they are not used routinely. The RL/OSL dosimeter was used in the di-
agnostic radiology department at Malmo¨ University Hospital to investigate
its potential for in vivo dosimetry in screening mammography (Aznar et al.,
2005a). One advantage of the RL/OSL dosimeter is its high sensitivity: very
small doses, such as those observed on the inferior surface of the breast dur-
ing a mammographic examination, can be measured. This quantity could
help determining if some patients are exposed to higher doses than expected
because of the specific density of their breasts. For our purposes, the most
significant difference with radiotherapy is that the requirement for accuracy
is much lower: the goal here is not to determine exactly what dose was de-
livered at a specific point in a patient, but to prevent potentially healthy
women from being exposed to a higher level of radiation that necessary. An-
other important factor is the size of the dosimeter: in vivo dosimetry should
not impair the diagnostic outcome of the mammographic examination. As a
result, the dosimeter should as small as possible, and should not be confused
with a potential malignancy on the mammogram.
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Figure 6.1: Illustration of a mammography measurement set up, showing the principal
components and the position of the fibers.
6.1 Dosimetry in mammography
6.1.1 Diagnostic equipment used in these experiments
All the experiments described in this chapter were performed with a mam-
mography unit (type Siemens Mammomat 3000) using a Molybdenum /
Molybdenum (Mo/Mo) anode/filter combination. The tube potential of the
mammography unit ranged from 23 to 35 kV. The images acquired during the
experiments were developed with a screen-film system (type Kodak Min-R
2190/Min-R 2000). Whenever relevant, the signals from the RL/OSL dosime-
ter were compared to the reading of a flat ionization chamber (type TB23344
from PTW Freiburg, Germany). A polymethylmethacrylate (PMMA) phan-
tom (area: 240 x 150 mm2) was combined to various thicknesses and was
used to simulate the presence of breast tissue. Mammography beams are
not very well qualified by the tube potential (in kV) alone: it is considered
that the half value layer (HVL) is a better indicator of beam quality. Hence,
HVL measurements have been performed for all the beams used in these ex-
periments. Figure 6.1 illustrates the mammography unit as well as several
important components.
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6.1.2 Quantities measured
In mammography, detectors are often positioned free in air, or at an interface
between tissue and air (e.g., on the skin). As a result, charged particle
equilibrium is not always presented, and the equality between kerma and
absorbed dose (see chapter 2) is not valid.In such conditions, the quantity
of interest is the air kerma as opposed to absorbed dose. The risk from
radiation for women undergoing mammography examinations is currently
described by the average absorbed dose to the glandular tissue. However,
this quantity is not directly measurable and must be calculated from beam-
related parameters. These parameters include the half-value layer (HVL) of
the beam and the entrance surface air kerma (ESAK). The ESAK represents
the incident air kerma at the breast surface measured free in air, and without
backscatter. The ESAK and the HVL values are usually measured with
an ionization chamber and without any patient present. For each patient
exposure, the loading of the x-ray tube (expressed in mAs) and compressed
breast thickness are recorded and the ESAK value can be calculated for that
particular exposure. Published conversion factors (Dance, 1990; Zoetelief
et al., 1996; Dance et al., 2000a) are then used to calculate the AGD from
the ESAK value (with the assumption that the breast composition is 50%
fat and 50% glandular tissue).
If in vivo measurements are performed, say with thermoluminescent (TL)
dosimeters placed on the superior surface of the breast, then the entrance
surface dose (ESD) is measured. The ESD is a measure of the radiation dose
absorbed by the skin where the x-ray beam enters the patient. The ESD
is then divided by an appropriate backscatter factor (BSF, tabulated as a
function of HVL) to obtain the ESAK, and then finally the AGD.
6.2 Basic dosimetry characteristics
6.2.1 Protocol
The output of a mammography unit is characterized by low photon energies
and high dose-rates. Typical RL and OSL signals generated by the Siemens
mammomat 3000 for 40 and 80 mAs pulses are sketched in figure 6.2.1. Be-
cause of the high dose rate and the short exposure times, the RL signal
appears as a high, narrow peak. Since the resulting absorbed doses (or air
kermas) considered are small, the OSL counts per reading are lower than
the RL counts per reading. Hence, counting statistics predict that for an
exposure of 40 mAs, the uncertainty is going to be higher for the OSL signal
than for the RL signal. This is the reverse of what we usually observe in
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Figure 6.2: Typical RL and OSL signals in mammography for 40mAs (a) and 80 mAs (b).
radiotherapy. As seen previously, because the RL signal is collected during
irradiation, it is potentially subject to some stem effect. However, in mam-
mography conditions, the signal generated in the light guide is insignificant
compared to the signal coming from the crystal (< 1%) as seen on figure 6.3.
Independent absorbed dose estimates were obtained by integrating either
the complete RL signal or OSL signal. For both signals (RL and OSL), some
background correction is performed, and the raw signal from each probe is
corrected to account for sensitivity differences. Because of the relatively small
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Figure 6.3: Stem effect in mammography conditions. Black symbols represent the RL
signal, and grey symbols show the signal coming from the light guide.
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absorbed doses in mammography conditions, it is possible to integrate the
entire OSL signal in about 100s. As mentioned previously, the RL signal is
subject to sensitivity changes with accumulated absorbed dose. As a conse-
quence, for an irradiation at a constant dose rate, the RL signal is going to
increase. In the case of mammography however, the resulting doses are too
small for any significant changes in RL sensitivity to occur (about 0.2% for
an absorbed dose of 10 mGy). Figure 6.4 illustrates this point.
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Figure 6.4: RL sensitivity changes. Even for a long (250 mAs) exposure, the increase in
RL signal is not noticeable.
6.2.2 Reproducibility and linearity
To test the reproducibility and the linearity of the response of the RL/OSL
dosimeter in mammography conditions, the RL/OSL fibers and the ioniza-
tion chamber were positioned right underneath the compression plate of the
mammography unit. No extra build-up or backscatter material was used.
Thirteen exposures were made at 29 kV and 40 mAs. RL and OSL data
were evaluated for both fibers, and normalized to ionization chamber read-
ings. The results are presented in table 6.1 for an air kerma of 4.5 mGy
and indicate a reproducibility of the order of 3%. The reproducibility of the
signals is also illustrated in figures 6.5(a) and 6.5(b). The uncertainty on the
RL data is dominated by counting statistics, while additional factors seem
to increase the uncertainty on the OSL results: these may include some in-
stability in the laser power, for example. The dose-response of the RL/OSL
system was also investigated at 29 kV, and figure 6.6 shows that the output
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Figure 6.5: Reproducibility of the RL and OSL signals for an air kerma of 4.5 mGy for
13 measurements. (a): integrated OSL signal, (b) first 7 seconds of the OSL signal , (c)
integrated RL signal and (d) visualization of the total RL signal.
Table 6.1: Reproducibility of the RL/OSL system (expressed as 1SD of 13 measurements
at 29 kV for an air kerma of 4.5 mGy)
Signal RL (counts/pC) OSL (counts/pC)
Fiber 48 1.9% 2.5%
Fiber 49 2.5% 2.8%
is linear with dose between 40 and 250 mAs (4.5-30 mGy). The minimum de-
tectable dose, calculated as 3 times the standard deviation of the background
is below 50 µGy for both fibers when using the RL signal, and approximately
200 µGy when using the OSL signal.
6.2.3 Energy dependence
Because of the low photon energies used in mammography, the photoelectric
effect is the predominant form of interaction. As a result, the energy depen-
dence of Al2O3:C is expected to be considerable. The variation in RL and
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Figure 6.6: Linearity of dose-response for several exposures at 29 kV (R-squared>0.999).
Data are normalized to their value at a 250 mAs exposure, corresponding to an air kerma
of 30 mGy. RL signal (crosses), OSL signal (circles).
OSL response of Al2O3:C as a function of tube potential was investigated
using the same experimental set-up as described in section 6.2.2, keeping the
tube loading constant at 40 mAs during all measurements. The RL and OSL
data were normalized to the simultaneous reading of the ionization chamber
(the energy dependence of this ionization chamber was checked at a primary
standards laboratory and is of the order of 1% for the range of energies used
in the study).
Figure 6.7 shows the obtained results as a function of HVL. The response
of the Al2O3:C crystal was found to increase by 18% when the tube potential
increased from 23 kV to 35 kV, corresponding to HVL 0.296 - 0.412 mm Al.
6.3 Quantities of clinical interest
6.3.1 Backscatter factors
Like TLDs, RL/OSL probes will measure ESD, and backscatter factors will
need to be established to convert ESD to ESAK. Backscatter factors for the
RL/OSL probes were defined as:
BSF =
Sphantom
Sair
(6.1)
where Sphantom is the signal at a point on the surface of the PMMA
phantom and Sair is the signal free in air at the same point without the
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Figure 6.7: Energy dependence of the RL/OSL signals. The data are divided by the
ionization chamber readings, and normalized to read unity at 29 kV. RL: crosses, OSL:
circles.
phantom. The phantoms used ranged from 1 to 6 cm in thickness. The
tube potential was kept at 29 kV, but the tube loading was increased as the
phantom thickness increased. The results are presented in table 6.2. The data
in table 6.2 suggest that full backscatter is achieved with 1 cm of PMMA.
Also, the average backscatter factor is 1.066± 0.004 (n=12) for the pooled RL
and OSL data (ignoring the differences in uncertainties and assuming that the
measurements are independent) where the indicated uncertainty (expressed
as 1SD) only includes the observed random variation from measurement to
measurement. The observed backscatter factor is slightly lower than the value
of 1.084 quoted for TLDs (with PMMA or breast tissue as the scattering
material) (Zoetelief et al., 1996). This discrepancy may reflect differences
in geometry (Chan and Doi, 1981) or in energy response of the different
materials.
6.3.2 Influence of phantom thickness
The sensitivity of the RL/OSL probes is sufficient to measure exit doses (of
the order of 0.5 mGy) in typical exposures. In the following experiment,
the thickness of the PMMA phantom was varied between 2 and 6 cm, while
the tube potential ranged from 23 to 35 kV. Fiber 49 was positioned at the
entrance surface of the phantom, while fiber 48 was placed on the exit surface.
The ratio“exit RL signal/entrance RL signal”was calculated in each case with
correction for the difference in sensitivity of the two probes. As illustrated
Risø-PhD-12(EN)
6.3 Quantities of clinical interest 91
Table 6.2: Measurements of backscatter factors (BSF) from a PMMA phantom. Three
exposures were performed in each set-up.
Thickness of Tube loading RL BSF OSL BSF
PMMA (cm) (mAs)
1 40 1.071 1.084
2 80 1.067 1.046
3 140 1.058 1.047
4 200 1.060 1.065
4.5 200 1.057 1.081
6 200 1.075 1.083
Mean ± 1SD 1.064 ± 0.003 1.068 ± 0.008
(n=6)
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Figure 6.8: Measurements with one probe (fiber 49) at the entrance surface, the other
(fiber 48) at the exit surface of a PMMA phantom. The ratios of RLexit/RLentrance are
presented for 23 kV (diamonds), 29 kV (triangles) and 35 kV (circles).
in figure 6.8, the exit/entrance RL signal ratio decreases with increasing
phantom thickness, and with decreasing tube potential. Uncertainty bars
were determined by counting statistics. Only in the most extreme case (6
cm PMMA and 23 kV) was the sensitivity of the exit probe too low to
provide a reliable RL signal. The OSL data provide similar results, but with
considerably higher uncertainties for low dose points.
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6.4 In vivo measurements
Before any in vivo measurements were performed, images of the probes po-
sitioned on several PMMA phantoms were acquired to test whether their
presence will degrade the diagnostic quality of the mammograms. Three ex-
perienced radiologists evaluated those images, and gave their approval for the
use of the probes during patient examination. In vivo measurements were
scheduled on three women coming to an ordinary screening examination (se-
lected to have different breast sizes and densities). Fiber 49 was attached
to the compression paddle in such a way that it was positioned between the
compression paddle and the upper part of the breast during the examina-
tion. Fiber 48 was positioned on the table of the mammography unit, and
was then in contact with the inferior surface of the breast (see figure 6.1).
The fibers were positioned so that they would not be superimposed on the
mammograms. Cranio-caudal (CC) and medio-lateral oblique (MLO) projec-
tions were used. Lead markers were attached to the compression paddle on
its upper side in order to get a more precise estimate of the compressed breast
thickness for each patient image. Except for these preparations, the standard
procedure for mammography screening was followed, including the use of a
tube potential of 29 kV, which is used routinely. Each patient received four
exposures (two for each breast). RL data were acquired for each individual
exposure. However, OSL readings were only performed after each patient’s
examination was completed. Hence, for each patient, four RL measurements
and one OSL measurement (representing the sum of four exposures) were
acquired. This protocol was chosen in order to avoid delays due to the longer
OSL reading procedure.
Finally, the radiologists evaluated the images from all three examinations
to assess the interference of the probes with the diagnostic quality of the im-
age. One radiologist also evaluated the screening images in order to quantify
the glandularity of the breast parenchyma.
HVL, ESAK and AGD were evaluated according to the European protocol
on dosimetry in mammography (Zoetelief et al., 1996). ESD was evaluated
from ESAK using a backscatter factor of 1.084 corresponding to a measured
HVL of 0.369 mm Al for the anode/filter combination Mo/Mo and the tube
potential of 29 kV. The fibers were positioned in such a way that their shad-
ows did not superimpose on the mammograms. Three radiologists viewed
the images and stated that neither the fiber dosimeters nor the lead markers
disturbed the reading of the mammograms due to their small sizes and char-
acteristic shapes that could not be confused with structures in the breast,
either benign or malignant (see figure 6.9). Single calcifications could have
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Entrance fiber
Exit fiber
Lead markers
Figure 6.9: Impact of the RL/OSL fibers on a mammogram.
been obscured, but this was not considered to impair significantly on early
breast cancer detection.
The estimated compressed breast thickness, ESAK and AGD are pre-
sented in table 6.3 together with estimated glandularity and breast parenchy-
mal category, which was found to be the same for each breast of the same
woman. Table 6.4 summarizes the results from RL/OSL measurements, com-
pared with the calculated ESD from the ionization chamber measurements.
RL and OSL results are expressed as counts, corrected for the different sensi-
tivities of the two probes. For measurements at a fixed kV (here, 29 kV), the
sum of the entrance RL signal seems to be a reliable estimator of the entrance
surface dose, as the ratio “RLentrance/ESD” has a standard deviation of 3%.
The exit doses could also be measured in vivo during all twelve exposures,
as seen from the “RLexit” signal (this signal was at least 4 times higher than
the background signal in all cases: one example is presented in figure 6.4).
The ratio of exit to entrance doses can be obtained for each individual image
Risø-PhD-12(EN)
94 Clinical applications in mammography
via RL analysis, or for each patient via OSL analysis. These estimates agree
within ± 10%.
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Figure 6.10: RL entrance and exit signals for one patient measurement.
6.4.1 Conclusion from the in vivo experiments
The RL/OSL dosimeter is capable of measuring real-time entrance as well
as exit absorbed doses and dose rates in mammography. The accuracy of
the system is satisfactory for in vivo mammography. In vivo entrance and
exit dose measurements of three women coming to a mammography screening
examination showed that the technique can be used for estimation of the ESD
and that the disturbances from the dosimeters on the image are acceptable.
After analyzing the experimental work some questions arose related to the
design of the probes and how it would influence the response of the RL/OSL
dosimetry system, especially in mammography beams. Energy dependence
could theoretically be minimized by using smaller crystals and varying the
thickness of the light protective material surrounding the crystal. These
issues have been investigated with Monte Carlo simulations using both cal-
culated and experimentally determined x-ray spectra in the mammography
energy range.
6.5 Probe design and energy dependence: a
Monte Carlo study
After analyzing the experimental work some questions arose related to the
design of the probes and how it would influence the response of the RL/OSL
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dosimetry system, especially in mammography beams. Energy dependence
could theoretically be minimized by using smaller crystals and varying the
thickness of the light protective material surrounding the crystal. These
issues have been investigated with Monte Carlo simulations using both cal-
culated and experimentally determined x-ray spectra in the mammography
energy range (Aznar et al., 2005b).
 
 
 
 
PMMA
Al
2
O
3
:C Polyester
Polyethylene
1 mm
Figure 6.11: Geometry of an RL/OSL probe used in EGSnrc simulations.
Monte Carlo simulations were performed with the code EGSnrc (Kawrakov
and Rogers, 2000). The user code DOSRZnrc was used to calculate the ab-
sorbed dose to the Al2O3:C crystal per unit photon fluence. The material
data files for EGSnrc were prepared with the pre-processor PEGS4 using
updated XCOM cross sections (Berger et al., 1999), (Hobeila and Seuntjens,
2002). The parameters were chosen in order to offer accurate simulations of
particle transport at low energies. The photon and electron cut-off energies
were both set to 1 keV, and Rayleigh scattering, spin effects, bound Compton
scattering, and Bremsstrahlung production were turned on. The calculations
were performed with 109 histories, which yielded a standard uncertainty of
0.1% when simulating the Al2O3:C crystal and 0.3-0.8% when the kerma in
the equivalent volumes of air, free in air was calculated.
The exact composition of the Araldite coating of the crystals was not
available, so Araldite was assimilated to a type of polyester (called“mylar”) in
the Monte Carlo simulations. In order to study the energy dependence of the
detector signal as a function of detector size and thickness of light-protective
material, Monte Carlo simulations were performed for three different detector
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diameters (0.30, 0.48 (actual size), and 0.80 mm). These calculations were
performed with an Al2O3:C crystal without any polyester coating. The effect
from varying the polyester coating was studied for three different thicknesses
(0, 0.24 (actual thickness), and 0.76 mm). The simulated geometry is shown
in figure 6.11 and it may be noted that no backscatter material was used
in the Monte Carlo simulations, which is due to the inherent demands on
cylindrical symmetry in the code DOSRZnrc. The experimental results are
the ones discussed in section 6.2.3 were obtained with only the breast support
at a distance of 45 mm behind the detector. It has been assumed that this
geometry generated an insignificant amount of scattered radiation to the
detector, particularly since the breast support was equipped with a grid but
no screen-film cassette.
6.5.1 Spectral data
Two different types of spectral data were used in the Monte Carlo simula-
tions; i) Calculated data obtained from the “Catalogue of diagnostic x-ray
spectra and other data” published by the Institute of Physics and Engineer-
ing in Medicine (IPEM, 1997), and ii) Measured spectral data, previously
obtained at Sahlgrenska University Hospital in Go¨teborg using a Compton
scattering spectrometer (Spectro-X, RTI Electronics) and a mammography
unit of the same type as the one used for the RL/OSL measurements (Siemens
Mammomat 3000).
Measured spectral data and RL/OSL measurements were all obtained
with the Mo/Mo anode/filter combination. Using the IPEM computer pro-
gram, two spectra were processed for 25 kV and 31 kV with a molybdenum
target, an anode angle of 10 degrees. The following attenuating materials
were included: 0.03 mm of molybdenum, 1 mm of beryllium, 500 mm of air
and 1.93 mm of PMMA corresponding to the thickness of the breast com-
pression plate used during the RL/OSL measurements. The half value layer
(HVL) of the resulting beam, as obtained with the IPEM program, was 0.30
mm of Al for 25 kV (mean energy 16.0 keV), and 0.36 mm of Al for 31 kV
(mean energy 17.0 keV). Measured spectral data were directly available for
25 kV. However, to be able to match the spectrum at the higher tube voltage
used in the RL/OSL measurements, 31 kV was obtained via interpolation be-
tween 30 kV and 32 kV. The error introduced by this procedure is expected
to be insignificant considering the observed shapes of the spectra obtained
for the two surrounding tube voltages. The mean energy for the measured 25
kV and 31 kV spectra were 16.1 keV and 17.1 keV, respectively. The HVL,
related to the measured spectral data, was obtained without the compres-
sion plate (Thilander Klang, 1997). For 25 kV, a value of 0.284 mm Al was
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Figure 6.12: Spectra used in EGSnrc. The energy fluence normalized to the area under
the distribution, Φe, is plotted versus photon energy. Solid line with symbols: IPEM data,
solid line: measured data, dotted line: modified measured data.
obtained. Data were not available for 31 kV, but interpolation between 28
kV and 32 kV yields 0.344 mm Al for this tube potential. For comparison,
modified spectral data were also included in the study. These spectra have a
more narrow energy distribution around the peak values, and are further de-
scribed in a previous published work (Dance et al., 2000b). The HVL values
corresponding to the modified spectra were, 0.288 mm Al and 0.355 mm Al,
respectively. The three different spectral distributions are compared for 25
kV in figure 6.12(a), where all results have been normalized to the area under
each distribution. It may be noted that the measured data were obtained
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with a finer energy resolution than the data obtained from IPEM (0.1 keV
vs. 0.5 keV).
6.5.2 Results
The absorbed dose to the Al2O3:C crystal (Dc) and the air kerma at the cor-
responding position free in air (Kair) free in air was calculated with EGSnrc
for the two beam qualities described above, using the dimensions of the real
detector system (see figure 6.11). The obtained ratio Dc/Kair was compared
with the experiments from section 6.2.3. The Monte Carlo determined in-
crease in response from 25 kV to 31 kV was found to be 5.6% using the
IPEM calculated spectra, and 7.3% using both the unmodified and the mod-
ified measured spectra (combined uncertainty of the Monte Carlo calculated
data = 1%, 1SD). The result obtained can be compared with the experimen-
tal value of 9% . The reproducibility of the RL/OSL being 2-3% (1SD), the
calculated and experimental values of the energy dependence agree within
the combined standard uncertainties of the two methods.
The diameter of the Al2O3:C crystal was varied between 0.30 mm and
0.80 mm, keeping the length constant at 2 mm. These calculations were
performed with a “naked” crystal, i.e. without any polyester coating. The
results are presented in table 6.5 for the three types of spectral data used.
The standard uncertainty of the Monte Carlo calculated ratio of between the
absorbed dose to the crystal and the air kerma free in air in an equivalent
volume (Dc/Kair) ranged between 0.5% for the largest crystal and 1.0% for
the smallest.
The coating of light-protective material surrounding the crystal was varied
between 0 and 0.76 mm, keeping the diameter of the crystal and its length at
constant values (0.24 mm and 2 mm, respectively). The obtained results are
given in table 6.6. The standard uncertainty of the Monte Carlo calculated
ratio between the absorbed dose to the crystal and the air kerma free in air
in an equivalent volume (Dc/Kair) was 0.7%.
6.5.3 Discussion
The energy dependence determined fromMonte Carlo simulations with EGSnrc
(5.6% with the IPEM calculated spectra, 7.3% with the unmodified and mod-
ified spectra) agrees with the previously determined experimental result (9%)
considering the uncertainties in calculated and measured values. The com-
bined standard uncertainty of the Monte Carlo calculated results were 1.0%
(1 SD) in all three cases. The standard uncertainty of the experimental value
is estimated to be around 4% based on the reproducibility of the RL/OSL
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Table 6.5: Ratios of Monte Carlo calculated values of absorbed dose crystal and air kerma
for three various diameters (ø). Two beam qualities and three different spectral distribu-
tions were included in the comparison. The thickness of light-protective material around
the crystal was set to 0 mm. The standard uncertainty of calculated ratios was 0.3% for
the largest crystal, 0.5% for the middle-sized crystal and 0.8% for the smallest. meas refers
to the measured spectra and modif to the modified measured spectra. Incr represents the
percentage increase in Dc/Dair from exposure in a 25kV beam to exposure in a 31 kV
beam.
Tube Dc/Dair Dc/Dair Dc/Dair
kV 0.30 mm ø 0.48 mm ø 0.80 mm ø
spectra IPEM meas modif IPEM meas modif IPEM meas modif
25 kV 2.74 2.79 2.78 2.41 2.41 2.40 1.96 1.97 1.97
31 kV 2.83 2.87 2.87 2.53 2.57 2.56 2.13 2.17 2.17
Incr.
(%) 3.3 2.9 3.2 5.0 6.6 6.7 8.7 10.2 10.2
Table 6.6: Ratios of Monte Carlo calculated values of absorbed dose to the crystal and air
kerma free in air for three various thicknesses of the light protective material surrounding
the crystal. Two beam qualities and three different spectral distributions were included in
the comparison. The diameter of the crystal was set to 0.48 mm. The standard uncertainty
of calculated ratios was 0.5%. meas refers to the measured spectra and modif to the
modified measured spectra. Incr represents the percentage increase in Dc/Dair from
exposure in a 25kV beam to exposure in a 31 kV beam.
Tube Dc-Dair Dc-Dair Dc-Dair
kV 0 mm 0.24 mm 0.76 mm
spectra IPEM meas modif IPEM meas modif IPEM meas modif
25 kV 2.41 2.41 2.40 2.33 2.33 2.32 2.18 2.18 2.17
31 kV 2.53 2.57 2.56 2.46 2.50 2.49 2.33 2.37 2.37
Incr.
(%) 5.0 6.6 6.7 5.6 7.3 7.3 6.9 8.7 9.2
system and the uncertainty in air kerma determined with the ionization cham-
ber. The obtained results encourage the concept of using EGSnrc and the
adopted simulated geometry for further studies of the present detector sys-
tem in mammography. The results of the Monte Carlo simulations indicate
that a minor improvement of the energy dependence could be achieved by re-
ducing the thickness of the light-protective material from the thickness used
at present (0.24 mm). However, some thickness will always be required due
to the need for light protection of the crystal, and the potential improvement
is less than 1% according to the obtained results. A larger reduction of the
energy dependence at photon beam qualities used in mammography could
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be achieved by reducing the size of the crystal. The effect when reducing the
diameter from 0.48 mm to 0.30 mm was 3% on average for the three spectra
used. the observed differences when using the different spectra are within
the uncertainties of the Monte Carlo results. However, it must be considered
that a reduction in size is followed by a decrease in sensitivity and a reason-
able compromise has to be found. The small differences in tables 6.5 and 6.6
between the results obtained using IPEM and measured data, respectively,
are caused by both small differences the three spectra, including differences
in the energy resolution (see figure 6.12(a)). The latter gives a slight effect on
the Monte Carlo sampling procedure. However, considering the uncertainty
of the Monte Carlo calculated results, 0.1% for Dc and 0.4-1.0% for Kair
(detector size 0.80 to 0.30 mm), the observed differences are insignificant.
6.6 Conclusion
The experiments presented in this chapter show the considerable potential of
the RL/OSL dosimetry system in mammography. Because of their small size,
the RL/OSL probes can be positioned on the breast during the mammogra-
phy examination without interfering with the diagnostic outcome. RL/OSL
signals can be used to obtain a reliable estimate of the entrance surface dose
to the breast. The high sensitivity of the RL/OSL probes enable to measure
absorbed doses on the exit (inferior) surface of the breast.Exit dose informa-
tion would help radiologists to determine whether some women are exposed
to higher doses as a result of mammography examinations because of the na-
ture of their breasts (size, density, etc.). The main concern of using Al2O3:C
in mammography is the energy dependence of the material, and Monte Carlo
calculations show that this parameter can be minimized by reducing slightly
the size of the crystal. In conclusion, RL/OSL optical fiber dosimetry is a
very promising technique for in vivo measurements in mammography.
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This thesis summarizes the application of a combined radioluminescence (RL)
and optically stimulated luminescence (OSL) dosimetry system developed
at Risø National Laboratory in the period 2001-2005 in close collaboration
with Malmo¨ University Hospital and Copenhagen University Hospital. This
research has particularly focused on the application of this system as an
in vivo dosimeter in radiation therapy and in mammography. The results
presented in this work show the considerable potential of RL/OSL optical-
fiber dosimetry using carbon-doped aluminum oxide (Al2O3:C ) as a detector.
One of the main advantages of the Al2O3:C RL/OSL dosimetry system
compared to existing dosimeters is the availability of two relatively indepen-
dent signals: the radioluminescence signal, obtained in real-time during the
irradiation, and the optically stimulated luminescence signal, acquired after
the treatment or radiographic examination. The RL signal is subject to two
phenomena, namely the “sensitization” of the detector and the “stem effect”
from the optical fiber. Both phenomena and their implications have been
discussed in detail in this thesis. Because of the difficulties involved in an-
alyzing the RL signal to obtain a reliable absorbed dose estimate, the OSL
signal was given primary focus in the early stages of this project. Later on,
however, some special attention was paid to the RL signal and resulted in
the development of two methods to correct the RL response. One, based on
dose-reference curve, corrected for the sensitization phenomenon and enables
real-time assessment of the dose rate delivered to the Al2O3:C crystal. The
other approach is a temporal gating method, which discriminates between the
true RL signal from the Al2O3:C crystal and the signal generated in the con-
necting optical fiber. These two analytic tools have shown to be invaluable
as they permit reliable dose rate and absorbed dose estimates in real-time
through the RL signal. The advantages in radiation therapy include a field-
by-field dose estimate in IMRT measurements. Other potential applications
of the RL signal would be in brachytherapy, where the accumulated dose and
instantaneous dose rate could be used as monitoring tools.
Risø-PhD-12(EN)
104 Conclusion
The precision and accuracy of the RL/OSL dosimetry system make it par-
ticularly attractive for in vivo dosimetry in radiation therapy. Three IMRT
patient measurements have been performed, which suggest that OSL esti-
mates can predict the absorbed dose delivered to the target volume within
2%. Phantom measurements show the same potential for the RL system, and
indicate that accuracy can be improved by carefully selecting the RL/OSL
fiber. Several sources of variability have been identified. Some of them sug-
gest that reliable dose assessments must be obtained according to a specific
protocol (e.g., it is recommended to let the system warm up). Other sources
of variability will necessitate further investigation, and possibly some minor
mechanical modifications of the dosimetry system (e.g., optical coupling be-
tween the fiber and the reader).
It should be noted, however, that an acceptance of the RL/OSL dosimetry
system as a clinical tool in in vivo radiation therapy dosimetry depends on
more than its overall accuracy. As was already mentioned in the introduc-
tion of this thesis, dosimetry systems must be affordable, as well as easy to
calibrate and use. Many dosimetry systems (MOSFETs, diamonds) are used
only marginally today as they can not easily compete with the existing sys-
tems (diodes and TLDs) in terms of costs and time investment. The RL/OSL
dosimetry system, if commercialized, will necessitate a primary investment
from a clinical institution to acquire the optical and electronic equipment.
However, the Al2O3:C fibers will be relatively cheap, making the overall sys-
tem financially competitive in the long run. In fact, the cost of Al2O3:C is so
low that the RL/OSL fibers may be designed as a disposable component of the
system, thereby eliminating any concern about sterilization. As far as user-
friendliness and calibration are concerned, the RL/OSL dosimetry system
would benefit from additional work to compete with silicon diodes. Mainly,
the laser bleaching time should be reduced and the stability of the system
should be improved so that monthly calibrations are sufficient. Though this
will take additional work, there are no fundamental obstacles to such im-
provements.
As far as in vivo dosimetry in mammography is concerned, the advantages
of the RL/OSL dosimetry system over existing systems are clear: the high-
sensitivity and fast readings of the RL/OSL system, as well as the unobtrusive
appearance of the detectors on the mammogram, make it a very attractive
alternative to TLDs. Additional information in the form of exit doses could
also provide a new light on radiation protection issues in mammography.
Other interesting applications of the RL/OSL system in diagnostic radiol-
ogy and radiation medicine are foreseen include fluoroscopic examinations,
dosimetry during special CT-scanning procedures or in vivo dosimetry in
nuclear medicine (for imaging and treatment purposes).
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